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Summary 
 
INT6 has been identified as a tumour suppressor protein. The INT6/EIF3E protein has been 
implicated in mouse and human breast carcinogenesis. In around 30% of human brest and 
lung carcinoma int6 has been found to be under-expressed. Histone mRNAs are unique in that 
they lack a 3’ polyadenosine tail.  Their translation and stability has been shown to be 
dependent on a 3’ stem-loop that binds to SLBP and SLIP1. Using a two-hybrid screen with 
INT6 as bait we report in this report the MIF4GD/SLIP1 protein as one of its interactors. 
Importantly for this work, SLIP1 bears homology to the middle domain of eIF4G. In 
mammalian cells, silencing of INT6 seems to marginally affect general translation.This study 
documents that INT6 binds to SLIP1 and SLBP and is required for efficient translation of 
histone mRNA. The knockdown of INT6 results in a 2 fold decrease in histone mRNA 
translation during S phase with.   
In another screen, Tax has been identified to bind INT6/eIF3E that is a subunit of the EIF3 
translation initiation factor required for efficient degradation of mRNAs by nonsense-
mediated mRNA decay (NMD). In line with this association, we show here that Tax inhibits 
this important cellular pathway and also interacts with the NMD core factor UPF1. Through 
specific protein-protein interactions Tax alters the normal recycling of UPF1 and morphology 
of processing bodies (P-bodies), the cytoplasmic structures which concentrate RNA 
degradation factors. Our data indicate that the effect of Tax on cellular genes expression is not 
restricted to transcriptional control and that this viral protein can favour production of viral 
RNAs by impeding their degradation. We observed a significant stabilization of canonical 
NMD targets and some viral RNAs. This work will contribute to a better understanding of 
both the basics of NMD and some effects of HTLV-1 infection on cell transformation. Tax, 
which trans-activates the expression of viral and cellular genes by binding to various 
enhancer-binding proteins needed for transcription, appears to also interfere with gene 
regulation at the post-transcriptional level by inactivating or modifying the mechanism of 
NMD. 
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Résumé 
 
Différentes observations montrent que la protéine INT6/eIF3E humaine possède une activité 
suppresseur de tumeurs. Il a été démontré que l’expression d’une forme tronquée de la 
protéine INT6 dans des lignées épithéliales mammaires humaines ou murines entraîne leur 
transformation.  Des souris « nude » exprimant à l’état hétérozygote INT6 tronquée 
développent des tumeurs mammaires. Enfin, il a été publié que chez l’homme le gène int6 
était sous-exprimé dans environ 30% des cancers du poumon non à petits cellules et que cette 
sous-expression était un facteur de mauvais pronostic. Des expériences de criblage double 
hybride avec INT6 comme appât ont identifié une nouvelle protéine humaine nommée 
MIF4GD/SLIP1 (SLBP Interacting Protein 1). Un effet de SLIP1 sur la traduction des ARN 
messager des histones a été montré. Les travaux récents que j’ai menés indiquent aussi 
qu’INT6 en interagissant avec SLIP intervient dans le contrôle de la stabilité et de la 
traduction des ARNs codant pour les histones. Un knockdown d’INT6 provoque une baise des 
niveaux des histones endogènes sans avoir un effet au niveau d’ARN. Mes études, en révélant 
un nouveau mécanisme de régulation du taux des histones dans lequel INT6 joue un rôle 
direct, permettent ainsi de faire le lien entre – d’une part – les fonctions connues de cette 
protéine dans la traduction et son contrôle et – d’autre part – les effets oncogéniques connus 
de son altération.  
Par ailleurs, l’étude de la fonction d’INT6 dans les cellules humaines réalisée au laboratoire 
d’accueil par ARN interférence montre une inhibition de la dégradation des ARNm possédant 
un codon stop prématuré par la voie du Nonsense Mediated mRNA Decay (NMD). Nous 
avons étudié son action par rapport aux ARNs HTLV-1. Nous avons observé une stabilisation 
significative des cibles de NMD. Ceci démontre que la protéine Tax interfère avec cette voie 
de dégradation des ARN d’une part en empêchant l’interaction entre UPF1 et INT6 et d’autre 
part en interagissant lui-même avec la protéine UPF1 phosphorylée. En agissant sur le NMD, 
Tax intervient à un niveau post transcriptionel qui pourrait avantager la réplication virale et 
aussi permettre la tolérance cellulaire aux mutations liées à l'effet mutagénique établi de Tax.  
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Part I Introduction 
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General Introduction.  
According to the World Health Organization (WHO) cancer is still one of the main causes 
of death in Western countries, accounting for 7.9 million deaths (around 13% of all deaths) in 
2007 ( Fig.1). The most frequent types of cancer differ between men and women but in 
general lung, stomach, liver, colon and breast cancer cause the most cancer deaths each year. 
Deaths from cancer worldwide are projected to continue rising, with an estimated 12 million 
deaths in 2030. 
 
  
Figure1. Worldwide cancer death distribution. (adapted from WHO, 2007) 
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Cancer is the result of an accumulation of mutations in specific genes, many of them 
falling under the scope of protooncogenes. Some of them will be presented later. Due to 
altered gene activity, normal control mechanisms are lost and abnormal cell growth and cell 
division take place. 
The etiology of cancers is one of the main fields of modern biology research. There are 
more than 100 distinct general types of cancer, and even more different subtypes of tumours 
which can be found within specific organs. This complexity raises a number of questions. 
Despite the plethora of cancer studies in the last decades the mechanisms of tumorigenesis 
remain to be defined with precision. Several theoretical models have been temporarily 
adapted to address the problem of cancer etiology. At present it is thought that the genome of 
every living organism contains inactive or weakly active cancer-causing genes called proto-
oncogenes. A number of physical, chemical or biological agents can mutate these proto-
oncogenes, leading to their activation or over-activation and turning them into cancer causing 
oncogenes. Symmetrically, other genes – called tumour suppressors – exhibit anti-cancer 
activities and must be inactivated for cancers to initiate. The functions of the genes involved 
in oncogenesis are varied, and include cell signalling and signal transduction, cell 
proliferation, cell death and senescence, immune signalling, DNA repair, cell adherence, etc. 
Because of this, it is thought that several different mutations affecting both proto-oncogenes 
and tumour suppressor genes are required to transition a cell from a normal phenotype to the 
most advanced stages of oncogenesis. Interestingly, some proto-oncogenes and tumour 
suppressor genes are commonly affected in most cancers (e.g. p53) while others are only 
affected in some subcategories of tumours. 
Among the various agents that can cause cancer, most can be classified as physical or 
chemical mutagens that directly or indirectly damage DNA. It is then the occasional failures 
of the DNA repair machinery that result in DNA sequence alterations which, when affecting a 
gene involved in cancer etiology, may position the cell one step further on the road to cancer. 
One type of causative agents stands apart for the diversity and complexity of means by which 
they can induce or facilitate transformation: the cancer causing viruses, or “oncoviruses”.  
During the 20
th
 century the realisation that viruses could participate in the oncogenic process 
was a real breakthrough in the domain of carcinogenesis (reviewed in: (Butel, 2000)). In 
particular several viruses were revealed to play a role in the etiology of several human 
cancers: hepatitis B and C viruses infections are involved in hepatocellular carcinoma, 
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papillomaviruses cause cancer of the cervix, Epstein–Barr virus is involved in lymphoma and 
carcinoma development. Interestingly many viruses which have not been associated with 
cancer nonetheless bear genes which when expressed in cells can induce transformation. It is 
also worth noting that the oncoviruses belong to several different taxonomic groups and 
include both DNA and RNA viruses. These two apparently unrelated observations can be 
explained by the hypothesis that in order to successfully replicate in host cells most viruses 
must deregulate cell cycle, nucleic acid metabolism and immune surveillance mechanisms 
that play a role in tumour suppression. Asides form this original mechanism of cellular 
transformation, viruses that accidentally or constitutively integrate their genome in the host 
cell’s DNA can also facilitate cancer progression by either of two mechanisms: (i) 
inactivation of a gene located at the locus of insertion; (ii) deregulation of the expression of 
genes around the locus of insertion by the proximity of viral promoters and or enhancers. 
Luckily, if viruses can cause cancer they can also teach us about it. Indeed, an interesting 
corollary of the capacity of viruses to induce some cancers is that these viruses make powerful 
tools for the study of oncogenic mechanisms in living organisms. 
The first discovered human retrovirus associated with human cancer was HTLV-1 
isolated in 1980. In subsequent years of intense studies, the protein Tax encoded by HTLV-1 
was both shown to be responsible for the viral genome’s transcriptional activation and 
identified as the major HTLV-1 oncoprotein, and thus became the subject of a large body of 
studies. 
Although viral infections might be an important cause of cancer, oncogenes may 
appear spontaneously in cells as a consequence of mutations. In complex organisms the 
phenotype of each cell is finely controlled and built on two complementary pillars: genome 
maintenance, itself the result of the quasi-absolute fidelity of DNA replication coupled with 
extensive DNA lesion repair; and corrects gene expression, which is subject to an extremely 
precise regulation. One of these is a quality control pathway called the Nonsense-Mediated 
mRNA Decay (NMD) which removes mRNAs that bear a “Premature Termination Codon” 
(PTC). Translation of an abnormal mRNA bearing a PTC would result in premature 
termination and release of incomplete, generally non-functional polypeptides from the 
ribosome. PTCs can occur as the result of transcriptional errors or mutations that either 
directly create a stop codon early in the coding sequence of the mRNA or indirectly create 
one as the result of a frameshift. It is known that up to 30% of all cancers involve Premature 
Stop Codons in tumour suppressor genes escaping the NMD and leading to truncated, 
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potential, dominant negative proteins (Lewis et al, 2003). PTCs can also result from non-
functional alternative splicing. Approximately 60–70% of human pre-mRNAs are 
alternatively spliced. Among these, 45% are predicted to have at least one spliced form that is 
expected to be targeted by NMD.  
 
An important feature of cancer cells is their intrinsically high genomic instability. 
Modified total cellular DNA content, chromosome anomalies and abnormal chromatin 
organization are used by pathologists as diagnostic markers for cancer (He et al, 2008; Khan 
et al, 2003; Komitowski et al, 1993; Michor et al, 2005). One of the pathways that can lead to 
genomic instability is altered histone synthesis. Histones govern the correct packaging of 
DNA and its transcriptional accessibility. Their synthesis is tightly coupled with that of DNA 
and is like it limited to the S phase. Impeding the fine balance between an excess or a lack of 
histones can result in chromatin rearrangements and physically weaken the DNA or make the 
genetic information inaccessible. These defects could in turn result in genomic instability and 
ultimately in cancer.    
 
The three points I briefly discuss above – viruses, NMD and histone homeostasis – 
seem to be completely independently connected to tumorigenesis. However from former 
studies one common feature emerges: the involvement of the INT6 (Integration Site 6 
protein), also termed the e subunit of Eukaryotic Initiation Factor 3 (eIF3e). The int6 
(Integration site 6) gene was originally identified as one of several genes that were frequently 
disrupted by Mouse Mammary Tumor Virus (MMTV) integration in MMTV-induced mouse 
mammary tumours (Marchetti et al, 1995; Miyazaki et al, 1995). As its alternate name of 
EIF3E indicates INT6 is part of the eukaryotic Initiation Factor 3 (Asano et al, 1997b). This 
protein is intensely studied in our laboratory. The cDNA coding for INT6 was isolated in a 
two-hybrid screen using the Tax protein of HTLV- 1 as bait (Desbois et al, 1996). More 
recently INT6 was identified by Christelle Morris in our group as an important factor of the 
NMD RNA surveillance pathway (Morris et al, 2007). 
It has been reported that a decreased level of INT6 correlates with human breast 
cancer, the most frequent type of cancer in women according to the WHO. The incidence of 
this cancer is increasing in the developing world and has been linked with various causes, 
among which a longer life expectancy, increased urbanization and adoption of a western 
lifestyle. Unfortunately the only efficient method of breast cancer prevention at present is 
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early detection. This method permits to reduce the breast cancer rate but cannot eliminate the 
majority of breast cancers. 
Recent published work confirms that in human breast cancer a low level of INT6 protein 
correlates with a bad prognostic. The aim of this work is to contribute to a better 
comprehension of the role of INT6 in oncogenesis. 
Considering the role of INT6 in the NMD pathway along with its known interaction with the 
HTLV-1 transactivator Tax, I will address here the question of whether this viral factor is able 
to act on NMD through INT6. I will show that Tax is indeed able to inhibit the NMD pathway 
by establishing contacts with both INT6 and the core factor of NMD, UPF1 (see Part II – 
Results – Article I).  
In a second part, I will present evidence that links INT6 with histone biogenesis. 
Because it is but one of the 13 subunits of the human eIF3 complex and, at that, one which 
does not appear to be essential for translation, INT6/EIF3E is rarely mentioned in relevant 
studies. Our data suggest that INT6, although dispensable for global translation, is crucial 
during a unique, non-classical translational mechanism, that of the cell-cycle dependent 
histone mRNAs. In this manuscript I will present some as yet undescribed functions of INT6 
in relationship with the regulation of the synthesis of histones. I will show that INT6-mediated 
regulation of histone levels intervenes through translational repression. I will also endeavour 
to demonstrate the implications of these novel activities of INT6 for such catastrophic 
processes as genomic instability and oncogenesis (see Part II – Results – Article II). 
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Chapter 1.  HTLV-1 
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The term “virus” was first used in the laboratories of Dimitri Ivanovski and Martinus 
Beijerink in 1890 to describe an “agent that causes infectious disease”. The curiosity caused 
by these “infectious particles” which were smaller then bacteria grew in the following 
decades. Interest in retroviruses goes back to 1904 when the first Equine Infectious Anemia 
Virus (EIAV) was identified (Vallee & Carre, 1904). Since then the Retroviridae family has 
become one of the most studied, mostly “thanks” to the infamous HIV pandemics that 
emerged in the 1980s and was estimated to affect 33 million persons in 2009.  
Retroviral infections have been found in a vast majority of pluricellular organisms, notably in 
groups as evolutionarily remote as insects, molluscs and vertebrates (Coffin, 1996). 
 
1. HTLV-1 
 
The Human T-cell Leukemia Virus type 1 (HTLV-1) was the first pathogenic human 
retrovirus discovered.  It was identified in 1980 in Bernard Poiesz’s and Robert Gallo’s 
laboratory from T-cells isolated from a patient presenting a cutaneous lymphoma (Gallo, 
2005; Poiesz et al, 1980). Further studies characterized threes other Human T- lymphotropic 
viruses (HTLV-2, HTLV-3 and HTLV-4) which were regrouped into the Deltaretrovirus 
genus of the Orthoretrovirinae subfamily. In this manuscript I will focus exclusively on 
HTLV-1. 
 
1.1. HTLV-1 associated diseases and epidemiology.  
 
 Shortly after its discovery, HTLV-1 was demonstrated to be a causative agent in Adult T-
Cell Leukemia (ATL), although the mechanisms underlying the virus-induced 
leukemogenesis are still only partially understood as of 2011. This made of HTLV-1 the first 
human onco-retrovirus ever discovered. Interestingly, HTLV-1 differs from most other known 
oncoretroviruses in that   it does not encode any homologue of cellular proto-oncogenes. 
(Jeang et al, 1990). 
HTLV-1 is also the etiological agent of a chronic progressive neuromyelopathy, tropical 
spastic paraparesis (TSP)/HTLV-1-associated myelopathy (HAM) (Yoshida et al, 1984). At 
the present estimations show that up to 2 million people are infected by HTLV-1 in Japan 
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(which is one of the endemic sources of this virus) and approximately 10 – 15 million 
worldwide (Proietti et al, 2005) (Fig.2). 
 
 
 
 
Figure 2. Worldwide distribution of HTLV-I infection. The map specifies the prevalence by region. Colours indicate 
current prevalence estimates based on population surveys and on studies in pregnant women and blood donors. In some 
countries, HTLV-1 infection is limited to certain population groups or areas. Changed from: (Verdonck et al, 2007).  
 
Importantly, the vast majority of individuals infected with HTLV-I do not develop any 
disease: the virus remains in the host throughout its life without causing any harm at all. Only 
a minority will develop a disease due to HTLV-I but this usually occurs only after several 
decades of infection. As mentioned briefly above two main types of diseases are caused by 
HTLV-I:  
- Adult T-cell Leukaemia/Lymphoma (ATL) (5% of infected patients, more often males 
then females). 
- tropical spastic paraparesis (TSP)/HTLV-1-associated myelopathy (HAM) (1% of 
infected patients). 
It is extremely rare for one individual to develop both diseases simultaneously. HTLV-I can 
also cause inflammation of the eye (uveitis), joints (arthritis), muscles (myositis), lung 
(alveolitis) and skin (dermatitis). These conditions are even less common than ATL and HAM 
and the skin condition is usually only seen in tropical climates. 
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1.1.1 ATL  
 
ATL results from monoclonal proliferation of transformed CD4+ T-lymphocytes which 
possess particular, multi-lobulated (“flower cells”) nuclei with condensed chromatin. The 
individuals present disease-associated symptoms including: hypercalcemia, skin lesions, 
hepatosplenomegaly and opportunistic infections. ATL patients poorly respond to 
chemotherapy. ATL appears in four types:  acute-, lymphoma-, chronic- and smouldering-
type. In general the prognostic is a five-year survival rate of 20%. Recently an antiviral 
therapy has been shown to significantly increase this survival rate in the early stage patients. 
In line with the long latency period it is estimated that ATL development involves several 
phases (Fig.3). 
 
 
 
 
Figure 3. Simplified schematic model showing events from infection with HTLV1 to onset of ATL. The scheme 
represents the hypothetical flow of events occurring between the initial infection with HTLV-1 and the onset of ATL.  
After a long latency period, ATL develops in about 5% of asymptomatic carriers. Tax expression is suppressed by several 
mechanisms, suggesting that Tax is not necessary at this stage. Although the occurrence of ATL is limited in patients 
infected with HTLV-1, ATL remains an aggressive form of adult leukaemia with no actual effective treatment 
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1.1.2 TSP/HTLV-1-associated myelopathy (HAM) 
The TSP/HAM is a neurodegenerative disease resulting in chronic inflammation, which 
affects the central neuronal system (spinal cord). It is characterized clinically by paraparesis 
associated with spasticity and hyper-reflexia (Höllsberg & Hafler, 1993; McFarlin & Blattner, 
1991). Although there is no cure for HAM/TSP a number of treatments are available. There 
are two approaches to treatment: treatment for the symptoms (e.g. pain or stiffness) and 
treatment of the cause (i.e. the inflammation in the spinal cord). 
 
1.2 The HTLV-1 particle and genome. 
 
 
Figure 4.  The HTLV viral particle and its structural components. Mature HTLV viral particles consist of a lipidic layer in 
which are inserted SU and TM, a protein shell composed of MA and the viral core composed of the viral RNA genomic 
(packaged as a dimer) surrounded by the CA protein. NC, RT, IN are also common components of the viral core.  
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HTLV-1 presents enveloped virions (Fig. 4) containing a nucleocapsid which protects the 
viral genome. The typical HTLV-1 particle is between 110 and 140 nm in diameter and 
contains two copies of a 9 kb ssRNA genome located in a protein capsid. As for most other 
retroviruses, the HTLV-1 genome contains gag, pol and env genes surrounded by two Long 
Terminal Repeat (LTR) sequences (Fig.5). The 5′ LTR functions as the viral promoter. Env 
codes for a 21 kDa transmembrane protein (TM) and a 46 kDa membrane surface 
glycoprotein (SU). Both pol and gag encode the so-called structural proteins of the virus. The 
pol gene codes for the reverse transcriptase (RT), integrase (IN) and protease (PR, responsible 
for the cleavage of HTLV-I structural proteins) enzymes. Gag codes for a poly-protein which 
is cleaved after translation within the Golgi apparatus by PR into the matrix (MA), capsid 
(CA) and nucleocapsid (NC) structural proteins. The space between the env gene and the 
3’LTR also contains the “pX” region, which contains four partially overlapping ORFs coding 
for regulatory factors (the misnamed “accessory” proteins): Tax, Rex, p12, p13, p30, p21 and 
HBZ on the minus strand of pX (Cavanagh et al, 2006; Gaudray et al, 2002; Matsuoka & 
Green, 2009; Satou et al, 2006).   
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Figure 5. Organization of the HTLV-1 proviral genome. A scheme of the HTLV-1 genome, alternatively spliced mRNAs, 
and putative proteins encoded by each mRNA is shown. ORFs are indicated by boxes and annotated with roman numerals. 
The gag, pol, and env structural genes are flanked by 5' and 3' LTRs. In the 3' portion of the genome is a pX region that 
encodes the Tax, Rex, p21, p12, p13 and p30 proteins in its various open reading frames. HBZ is encoded by a negative 
strand RNA derived from the 3' LTR.  
 
 
1.3. HTLV-1 transmission. 
HTLV-1 is usually transmitted from mother to infant (breast feeding), by sexual intercourse 
or by blood transfusion. All three of these methods require cell to cell contact, which means 
that transmission of a free viral particle from the infected individual to a virus-free individual 
is not enough:  an infected cell must be transmitted for contamination to occur. The contact 
between the infected and the uninfected cells is established by the formation of the so-called 
“viralogical synapse” (Fig.6), which is formed at the cell-cell junction by the Microtubule-
Organizing Center (MTOC), and where the viral genomic RNA and the Gag complex 
accumulates. The formation of the synapse is further stimulated by Tax. Three HTLV-1 
receptors are known to be important for HTLV-1 entry: the Glucose Transporter 1 (Glut1), 
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the Heparan Sulfate Proteoglycans and the Neuropilin-1 (Jones et al, 2005; Lambert et al, 
2009; Manel et al, 2003). 
HTLV-1 inserts randomly within the host’s genome. Due to an active immune response 
targeting the virus, proliferation of infected T-lymphocytes mainly occurs by cellular division. 
It has been shown that after the initial polyclonal stage this leads to an oligoclonal phase 
which eventually results in selection of a single clone with highly invasive properties. Thus 
the main proviral load is due to clonal expansion of the virus rather than to de novo spread.   
 
 
 
Figure 6. Formation of the viral synapse. Unlike many other viruses, cell-free human T-cell leukaemia virus type 1 (HTLV-
1) virions are largely non-infectious. This figure illustrates the cell–cell contact required to create a virological synapse 
through which the viral genome is transmitted from one cell to another. The roles played by lymphocyte function-associated 
antigen 1 (LFA1), and intercellular adhesion molecule 1 (ICAM1) in forming cell–cell contact are shown. Tax contributes to 
the formation of a microtubule organizing centre (MTOC). Adapted from: (Matsuoka & Jeang, 2007) 
 
 
1.4. The life cycle of HTLV-1.  
 
HTLV-1 has been shown to be able to successfully infect a multitude of cell types, including 
T and B cells, macrophages and fibroblasts (Jones et al, 2008; Koyanagi et al, 1993). The life 
cycle of HTLV-I is divided in two main parts.  The first includes (i) viral entry, (ii) reverse 
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transcription of the viral RNA genome into DNA, (iii) nuclear import of the proviral DNA 
genome, and (iv) integration of the proviral DNA into the host’s genome to form a provirus. 
The second includes (i) viral gene transcription and (ii) protein synthesis necessary for the 
viral gene expression and virion assembly (Fig.7.). 
The initial step of HTLV-1 invasion is the infection of a great number of lymphocytes by viral 
particles leading to the integration of the provirus and synthesis of viral proteins. HTLV-1 
oncogenic progression is extremely slow, and one of the best studied HTLV-1 factors thought 
to be involved in the process is the viral transactivator protein Tax (the particularities of this 
protein will be detailed later). Tax has been shown to be necessary and sufficient to transform 
mice fibroblasts (Tanaka et al, 1990) or to immortalize primary human T lymphocytes 
(Grassmann et al, 1992; Grassmann et al, 1989). Moreover, it has been reported that 
transgenic animals treated with a Tax expression vector develop tumours. Experiments with 
transgenic mice that express the HTLV-1 Tax oncoprotein in thymocytes, even led to the 
development of lymphoma-like pathologies (Hasegawa et al, 2006). These observations 
indicate that Tax is likely responsible for at least part of the oncogenic process initiated by 
HTLV-1 and suggest that studying this protein could be crucial for understanding (and 
eventually curing) ATL. 
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Figure 7. Viral replication in the host and virion formation. HTLV-1 contains the diploid ssRNA and several copies of 
reverse transcriptase (DNA polymerase). After infecting a cell, the reverse transcriptase is used to make the initial copies of 
viral DNA from viral RNA. Once a DNA strand has been synthesized, a complementary viral DNA strand is made. These 
double strand copies of viral DNA are inserted into the host-cell chromosome and host-cell RNA polymerase is used to make 
virus-related RNA. These RNA strands serve as templates for making new copies of the viral chromosomal RNA and serve 
also as mRNA. mRNA is translated into viral proteins that are used to make the virus envelope. New viral particles are 
assembled, bud from the plasma membrane, and are released. Adapted from Qiagen. 
 
 
1.5 HTLV-1 Accessory proteins. 
Under the control of the promoter located in the 5’LTR, HTLV-1 encodes several regulatory 
proteins that are responsible for HTLV-1 transactivation (Tax ⁄ Rex). Another promoter is 
placed in the 3’LTR of the viral genome and enhances the antisense transcription of the hbz 
gene coding for the HTLV-1 Basic leucine Zipper (HBZ). This protein is essential for 
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maintenance of malignant features of HTLV-1 infected T cells. For a long time the proteins 
p12, p13, p30, p21 were termed “accessory” and known as non-essential.  
 
1.5.1 p12 
p12 has been reported to associate with the Golgi Apparatus and Endoplasmic Reticulum and 
to increase the levels of intracellular Ca
2+
, thus stimulating cell proliferation and survival. 
HTLV-1 p12 also participates in viral evasion of the host’s immune response, in all likelihood 
as a result of its associating with immature forms of the Major Histocompatibility Complex 
class I (MHC I). Indeed, p12 has been shown to decrease the surface levels of transfected 
MHC-I by inducing its degradation by the proteasome (Bindhu et al, 2004; Van Prooyen et al, 
2010) 
 
1.5.2 p13 
p13 associates with the inner membrane of the mitochondria. Similarly to p12 it modulates the 
Ca
2+
 homeostasis which might have an impact on lymphocyte T activation via NFAT 
(Biasiotto et al, 2010). In addition p13 provokes K
+
 entry into mitochondria, which results in 
membrane depolarisation. The massive changes in ion charge this induces favour the 
production of Reactive Oxygen Species (ROS). It has been proposed that p13 might exert 
distinct functions depending on its intracellular localization. In the nucleus p13 binds Tax and 
inhibits its transcriptional activity which could lead to turnover of infected cells and the 
balance between viral latency and productive infection (Silic-Benussi et al, 2010). 
 
1.5.3 P30 
The p30 protein acts as a negative regulator. p30 restrains the export of the tax/rex RNAs 
which results in slower Tax/Rex protein synthesis and inhibits the viral transcription and 
general RNA export. Lower Tax/Rex expression results in a decrease of viral particle 
production. This makes p30 a protein responsible for the induction of a viral latent period 
within the infected cells (Nicot et al, 2004).  
 
1.5.4 REX 
Synthesized from a multi-spliced viral mRNA (ORF III), this 21 kDa protein is responsible 
for repression of splicing of viral RNA and promotes their nuclear export. It is expressed 
during the early phase of infection and governs the production of essential proteins during the 
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late phase of infection. In vivo studies demonstrated that Rex is essential for virion 
production. Rex binds to the Rex Response Element (RxRE) and coordinates the cytoplasmic 
accumulation of spliced as well as unspliced forms of the viral mRNAs. Rex synthesis has 
been shown to be required for viral replication to initiate. Thus Rex is a post-transcriptional 
regulator and is pivotal for the control of viral latency and gene expression.  
 
1.5.5HBZ  
One recently identified HTLV-1 proteins is the HTLV-1 bZIP Factor (HBZ). This 30kDa 
(209 AA) protein contains a bZIP domain in its C-terminal part and a transcription activator 
domain in its N-terminal part. HBZ is encoded by the antisense strand of the viral RNA and is 
transcribed from the 3’LTR. It has been found to interact with the factors JunB, JunD, CREB 
and CBP/p300 to modulate gene transcription. HBZ down regulates Tax functions, which 
implies an additional level of complexity in the regulation of HTLV-1 gene expression.  HBZ 
hinders the interaction between Tax and CREB on the 5’LTR thereby blocking the 
recruitment of CBP/p300 on this promoter. In consequence the transcription of other viral 
genes is stopped.  The early phase of infection is characterized by the expression of the genes 
under the control of the 5’LTR promoter. Proteins participate in infectious virion formation. 
The natural immune response is directed against Gag, Env and Tax, the outcome being the 
removal of infected cells. Since HBZ downregulates the synthesis of Gag, Env and Tax, it 
circumvents the immune response of the host. Of all the viral genes, only the expression of 
the antisense factor hbz is clearly detectable at all stages of the infection at the RNA level 
(Satou et al, 2006; Suemori et al, 2009). The current hypothesis is that the hbz gene has a dual 
functionality: hbz mRNA promotes T-cell proliferation, while the HBZ protein suppresses 
Tax-mediated viral transcription. 
 
1.5.6 TAX  
One of the most studied “accessory proteins” of HTLV-1 is the oncoprotein Tax (Grassmann 
et al, 2005). Tax (encoded by the ORFIV in the pX region) associates with the Tax 
Responsive Element (TRE or TxRE), an imperfectly conserved (between HTLV subtypes) 
21-base-pair repeat sequence containing an octamer motif TGACG(T/A)(C/G)(T/A’). 
Association of Tax with the TRE stimulates the expression of the HTLV-1 provirus. 
Initial studies showed that Tax  a 40 kDa (353 AA residues) protein is localized preferentially 
in the cell nucleus, but it is currently admitted that Tax is able to shuttle between the nucleus 
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and the cytoplasm (Kashanchi & Brady, 2005). It has been demonstrated that Tax associates 
with numerous proteins in special Tax-bodies or nuclear speckles (Semmes & Jeang, 1996) 
and even to localize to centrosomes. The localization and so the interactions are highly 
dynamic and undergo rapid changes under specific conditions such as stress.   
Tax is the first protein expressed after HTLV-1 infection. Its importance seems to be 
restricted to the initial steps of cellular transformation. Tax presents pleiotropic activities 
which deregulate numerous cellular pathways. It is known to activate important transcription 
factors like Nuclear Factor-Kappa B (NF-κB), Activator Protein 1 (AP-1), Serum Responsive 
Factor (SRF) and cyclic-AMP-Response Element-Binding protein (CREB) (Li & Gaynor, 
1999; Sun & Yamaoka, 2005; Winter & Marriott, 2007). Through these interactions Tax 
induces aberrant cellular proliferation and genomic instability and inhibits DNA damage 
repair and apoptosis. Notably all these pathways remain active in ATL cells. At late stages of 
ATL Tax expression is barely detectable. This means that others factors or cellular events 
intervene in late ATL stages. Another very important viral protein whose RNAs expression is 
clearly detectable at this stage is HBZ (described above).  
1.5.6.1 Tax interactome summary and pathways deregulated. 
It is difficult to make an exhaustive and accurate list of all pathways on which Tax is known 
or thought to have an impact, but this multiplicity in itself suggests that the protein could be 
interacting with many different partners. Indeed, a recent review describes around 100 
interaction partners for Tax (Boxus et al, 2008). Tax presents several features of a multiple 
interaction protein such as presence in both the cytoplasm and the nucleus, a poorly structured 
tridimensional conformation and susceptibility to multiple posttranscriptional modifications – 
notably phosphorylation, acetylation, ubiquitinylation and SUMOylation (Boxus et al, 2008). 
Many of the known interactions between Tax and cellular factors are high affinity, suggesting 
that these interactions play an important role in the viral life cycle. However, it should be 
noted that because many of these interactions have been described in vitro in absence of other 
HTLV-1 proteins, some of them may not actually occur during wt HTLV-1 infection, as other 
viral partners of Tax or the virus-induced modifications of the cell may prevent their 
occurrence. As for the many interactions which have been validated in vivo, a study of their 
relevance to the viral life cycle in the context of a living organism is often lacking and would 
present a great interest. In this respect, a recent work opens interesting possibilities by 
proposing a new tool which mimics HTLV-1 infection in a non-human model: the “Human 
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Immune System” (HIS) Rag2-/-γc
-/-
 mouse model (Villaudy et al, 2011). This animal model is 
derived from newborn mice by intrahepatic transplantation of human CD34
+
 cord blood cells, 
which results in the development of the major functional components of the human adaptive 
immune system in the host mouse (Chicha et al, 2005). Analysis of the partners of Tax in this 
model would give a more physiological picture of the real Tax interactome and thus yield 
more precise insights in the complex way Tax acts upon a cell.  
In this manuscript I will concentrate on the subset of factors and/or pathways known or 
thought to be targeted by Tax that are the most relevant to our study of the links between Tax 
and the NMD pathway (Table 1). Tax acts as a stimulator of proliferation, but also as a 
mutagen and as an activator of genomic instability. In fact, Tax deregulates directly or 
indirectly (by associating with proteins involved in post-transcriptional control) the 
expression of more than one hundred genes (reviewed in: (Boxus et al, 2008)). 
Some of the main pathways activated by Tax are summarized in the table below: 
Mechanism Factor Effect 
Transcription AP-1 
CREB (CBP/p300) 
NF-κB, SRF, TBP 
Increased cellular proliferation; 
impaired histone synthesis, octamer 
disassembly; chromatin transition  
Cell-cycle 
progression 
CDK2 and 4 
Cyclin D2 and 3 
E2F1, p16, p21/WAF1 
Accelerated G1-S phase progression 
and “hyper-replication” 
Chromatin 
remodelling 
SWI/SNF family Activation of specific cellular promoters 
Cellular 
checkpoint and 
DNA repair 
CHK1 and 2 
DNA Topoisomerase I 
Ku80, MAD1, Rad51,p53 
Telomerase  
Genomic instability, aneuploidy 
Signal 
transduction, 
regulation 
- Nuclear receptors 
 
- SMAD1 
 
 
 
 
- ARE-containing 
genes (TNFα, GM-
CSF) 
- TTP 
- Inhibition of the transcription of 
target genes 
- Cellular resistance to TGFβ; 
interaction with immune 
surveillance; stimulation of 
expression of proteins involved in 
viral binding and fusion (Glut1) 
- Inhibition of cell proliferation, 
differentiation and death, immune 
response 
- Stabilization of TNFα mRNA 
favouring cell transformation 
Table.1 Some of the interaction partners of Tax and the effect of the interaction on cellular biology. 
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One particular interaction partner is of high interest to me: it has been demonstrated via a two 
hybrid screen that Tax interacts with the e subunit of the eIF3 translation complex, a protein 
also termed INT6. So far no function has been accredited to this interaction (Desbois et al, 
1996). 
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Chapter 2   INT6/EIF3E 
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2. Integration Site 6, the gene (int6) and the protein (INT6/eIF3E). 
 
The gene int6, coding for the INT6 protein, was first identified in 1995. Having then been 
independently re-discovered by several groups over the years, the gene is also known as 
EIF3E, INT6, EIF3S6, EIF3-P48, eIF3-p46, LOC3646 or moyshoy, PCI.3.    
The int6 gene is located on chromosome 8, spans a respectable 254 kb and contains 25 
distinct introns. The int6 (“Integration site 6 “) gene has been conserved during evolution 
from yeast to mammals, which points it out as an essential cellular factor. Int6 codes for a 52 
kDa proto-oncoprotein ubiquitously present in the cell. In 1997 INT6 was identified to 
correspond to the “e” subunit of the eIF3 initiation factor (Asano et al, 1997b). This shuffling 
protein holds a Nuclear Export Sequence (NES) as well as a Nuclear Localisation Signal 
(NLS) (Guo & Sen, 2000) (Fig.8). In mammals, int6 is widely expressed. A transcript of 
about 1.6 kb is found in the brain, lung, heart, liver, spleen, pancreas, skeletal muscle, 
mammary glands, lymph nodes, and thymus (Desbois et al, 1996). However Northern Blot 
analysis revealed variable expression levels. The highest has been found in pancreas, muscles, 
and lymphoid tissues. 
 
 
Figure 8. INT6 protein functional domains. This 445 AA protein has a Nuclear Export Signal on it N-terminal, internal 
ATGs (denoting alternative start sites located approximately 40 amino acids downstream of the predominant start site); NLS, 
bipartite Nuclear Localization Sequences (at amino acid 268 and 310); PCI domain (proteasome, COP9 signalosome, 
initiation factor 3/proteasome subunits). 
 
 
 
38 
 
2.1 Identifiction of INT6 
In the 90ties of the last century three independent studies have led to the identification of 
INT6: 
- The int6 gene was demonstrated to be a frequent site of Mouse Mammary Tumor 
Virus (MMTV) integration (Marchetti et al, 1995; Miyazaki et al, 1995). 
- The human cDNA coding for INT6 was isolated in a two-hybrid screen using the Tax 
protein of HTLV- 1 as bait (Desbois et al, 1996). 
- The INT6 protein was characterized as a subunit of translation initiation factor eIF3 
(Asano et al, 1997b). 
 
2.2 MMTV and the int6 genes. 
The Mouse Mammary Tumor Virus (MMTV) is a retrovirus that induces carcinomas in mice. 
Unlike most transforming retroviruses, it causes malignant transformation by insertion and 
clonal expansion of cells, rather than by directly encoding an oncogene. MMTV (similarly to 
avian leukosis virus (ALV) and murine leukemia virus (MLV)) elicits tumorigenesis trough 
insertional mutagenesis. This means that tumour formation caused by these viruses depends 
foremost on the host cellular proto-oncogenes, mutated as a consequence of proviral 
integration. Viral integration into the int6 gene occurs at any of several introns and leads to 
the synthesis of truncated mRNAs, expression of a truncated form of INT6 and tumour 
development in mice (Marchetti et al, 1995). Both loss of expression of the modified allele or 
production of shortened forms of the protein can deregulate cell growth.  
In MMTV infected mice six different loci of int genes have been identified. The name “int” 
for “integration site” mirrors the preferences of MMTV to integrate within these genes.  Most 
of them, like the: int1/wnt1, wnt3, wnt 10B, int2/fgf3, fgf4, int3/notch and int6 have been 
identified as affected while mammary tumours occurred (Tekmal & Keshava, 1997). 
In this manuscript I will focus on the int6 (Integration site 6) gene, the sixth member of the int 
genes family which has been demonstrated to be a frequent site were the MMTV integrates. 
The integration of the provirus has been studied in preneoplastic and neoplastic mammary 
lesions.  
2.3 INT6 as a subunit of eIF3. 
The eukaryotic translation initiation factor eIF3 consists of 6 proteins in Saccharomyces 
cerevisiae and 13 protein subunits in human cells – consecutively named eIF3a - l)(Browning 
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et al, 2001; Zhou et al, 2008). With a weight of around 800kDa it is the largest initiation 
factor in mammals. The eIF3 directs the interactions between mRNA the 40S ribosomal 
subunit and initiator Met-tRNA, promotes translation re-initiation and functions as a platform 
for interactions with other regulatory eIFs (Hinnebusch, 2006). INT6 has been shown to be an 
eIF3 component which is dispensable for general translation and forms together with subunits 
a, b, c, f, and h the functional core of eIF3. From fission yeast studies it is known that INT6 
mutants present a very slight inhibition of the translation rate and a poor decrease in global 
polysome content (Akiyoshi et al, 2001; Bandyopadhyay et al, 2000; Zhou et al, 2005). 
Intriguingly a study reported the presence of two distinct eIF3 complexes in fission yeast. One 
of those, defined by the Csn7Bp/eIF3m subunit, seems to be responsible for the translation of 
an important part of mRNAs, whereas the other, containing INT6, is associated with the 
regulation of a more restricted mRNA subset (Zhou et al, 2005).  Thus in contrast to other 
eIF3 subunits, INT6 is not essential for global translation but seems to regulate the translation 
of specific classes of mRNAs. INT6 was reported to act positively or negatively on the 
presence of several mRNAs in polysomes. (Grzmil et al, 2010). INT6 positively regulates a 
group of mRNAs encoding proteins involved in coagulation, taxis and endocytosis, and 
negatively regulates genes controlling cell division and adhesion. 
 
2.4 HTLV-1 Tax INT6. 
Human INT6 has been identified in our laboratory as an interacting partner of the Human T-
cell Leukemia Virus type 1 (HTLV-1) protein Tax in a two-hybrid screen (Desbois et al, 
1996). A cDNA library of immortalized human B lymphocytes transformed by the Epstein-
Barr Virus was screened using the entire Tax protein as bait and led to the isolation of human 
INT6. The interaction between Tax and INT6 was further confirmed by immunoprecipitation 
experiments and was confirmed to be strong and specific. The complex between both proteins 
was found to be cytoplasmic, whereas in normal cells INT6 is present both in the cytoplasm 
and the nucleus (Desbois et al, 1996; Watkins & Norbury, 2004b). INT6 has been 
demonstrated to be a component of specific nuclear foci called ND10 (nuclear domain 10), or 
PML bodies after their defining component, the Promyelocytic Leukemia Protein (PML). 
Between 5 and 50 of these bodies are found in different cell types, and they have been 
proposed to participate – among other roles – in tumour suppression. Interestingly localisation 
of Tax to PML bodies is lost in Tax-transfected cells (Desbois et al, 1996). 
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2.5 INT6 in the NMD. 
Recent studies in our laboratory led to the demonstration that INT6 interacts with UPF2, 
UPF1 and CBP80, three important Nonsense mRNA Mediated Decay (NMD) players, and 
revealed INT6 as a new NMD-factor (Morris et al, 2007). NMD is a mRNA quality control 
mechanism which leads to degradation of mRNAs which include a Premature Termination 
Codon (PTC) and necessitates a first translation of the mRNA (reviewed in: (Chang et al, 
2007; Ishigaki et al, 2001; Muhlemann, 2008)) 
The NMD mechanism will be described in details in chapter 3 of this manuscript. 
 
2.6 INT6 and the proteasome. 
Other studies identified INT6 as a component of the 26S Proteasome-COP9 signalosome. 
(Hoareau Alves et al, 2002; Karniol et al, 1998; Yahalom et al, 2001; Yen & Chang, 2003). 
INT6 contains a Proteasome-COP9 (constitutive photomorphogenesis 9, (Lee et al, 2011)) 
signalosome (CSN)-Initiation of translation (PCI) domain (Hofmann & Bucher, 1998). Co-
purification studies performed in diverse species (Arabidopsis thaliana, human) indicate that 
INT6 associates with several subunits of the CSN. The CSN a target for kinase activity and 
has been to coordinate activity of kinases (Harari-Steinberg & Chamovitz, 2004). It is 
involved in regulation of the degradation of cellular proteins in mammals and in 
photomorphogenesis in plants. Intriguingly the truncated INT6 proteins, induced by MMTV 
integration, (INT6ΔC) lack the PCI domain, suggesting that its loss disrupts INT6 functions. 
It is probable that INT6 plays a role of a regulatory protein to coordinate activity of all three 
complexes (Proteasome – CSN – eIF3). 
Such a domain exists in several subunits of the lid of the 19S proteasome regulatory particle, 
of the CSN and of eIF3 (Hoareau Alves et al, 2002; Karniol et al, 1998; Yahalom et al, 2001). 
PCI-domain bearing subunits of the 19S proteasome, CSN are involved in protein 
degradation, SCF E3 ubiquitin ligase regulation and mRNA translation, respectively. It has 
been hypothesized that they may play a scaffold role (Pick et al, 2009). The 26S proteasome 
degrades poly-ubiquitinylated cellular proteins (Baumeister et al, 1998). It contains two main 
parts: the 19S regulatory complex and the 20S core complex. INT6 binds to the Rpt4 protein 
which is one of the six AAAs forming the base of the 19S regulatory particle. These ATPases 
are believed to play an important role by unfolding the protein prior to degradation by the 20S 
core proteasome subunits.   
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2.7 Other INT6-interaction factors 
INT6 has been identified in other numerous studies summarized below (Table 2). Some of 
them are associated with specific functions in the cell, whilst others need to be explored. 
 
 
Table 2.  Overview of the many interactions and roles of INT6 in mammalian cells. 
 
 
 
Mechanism/Pathway Interaction 
Factors 
INT6 Function/Effect  References  
INT6 
NMD UPF1, 
UPF2 
Stimulation of mRNA 
decay.  
(Morris et al, 2007) 
NMD CBP80 Pioneer translation round (Morris et al, 2007) 
DNA damage and 
replication control  
MCM7 Regulation of MCM7 
stability during S phase. 
(Buchsbaum et al, 
2007) 
Degradation of cellular 
proteins 
CSN: 
CSN3, 
CSN6 and 
CSN7a 
Not Defined (Hoareau Alves et 
al, 2002) 
 
Polyubiqutinilation  
(degrades poly-
ubiquitinylated cellular 
proteins) 
26S 
Proteasome: 
Rpt4 in the 
19S 
HC3 in the 
20S 
INT6 stabilizes the complex  (Asano et al, 1997a; 
Hoareau Alves et 
al, 2002; Karniol & 
Chamovitz, 2000; 
Yen & Chang, 
2003; Zhou et al, 
2005) 
HIF2α dependent 
angiogenesis 
HIF2α Degradation (Chen et al, 2007)  
RING-finger domain, 
thus it is a presumed E3 
ligase for 
polyubiquitination. 
Rfp (RING-
finger 
protein) 
PML bodies localization 
Degradation E3 ligase 
(Desbois et al, 
1996; Hoareau 
Alves et al, 2002) 
Translation initiation 
(Formation of the 43S 
PIC) 
EIF4G-1 eIF4G binds to eIF3 through 
INT6  
 
(LeFebvre et al, 
2006; Morris-
Desbois et al, 2001) 
Translation initiation 
(Further studies 
required) 
HSPC021  
eIF3-
associated 
protein that 
can be  
phosphorylated 
on tyrosine  
Directly interacts with Int-6. (Morris-Desbois et 
al, 2001) 
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2.8. INT6 in tumorigenesis: a double edged protein?   
Different subunits of the eIF3 complex have been described to participate in tumour 
development and malignant transformation. Evidence comes from experiments performed in 
immortal fibroblasts. The expression of any of the following five subunits of eIF3: a, b, c, h or 
i, resulted in malignant transformation (Ahlemann et al, 2006; Savinainen et al, 2006; Zhang 
et al, 2009). The implication of INT6 (EIF3E) in tumorigenesis is more complex. Various 
studies suggested contradictory roles of INT6 in either tumour suppression or oncogenesis 
(Buttitta et al, 2005; Chen et al, 2007; Marchetti et al, 2001b; Rasmussen et al, 2001). 
 
The expression of INT6 appears to be altered in human cancers. INT6 levels are 
downregulated in 27% of non-small cell lung cancer, (Buttitta et al, 2005) and in 30% of 
human breast cancer in both the tumours and in the stroma surrounding the tumour (Finak et 
al, 2008; Marchetti et al, 2001a; Umar et al, 2009; van 't Veer et al, 2002). However it is 
difficult to study more deeply the role of INT6 disruption during tumorigenesis since a knock-
down animal model does not exist: attempts have been done for both Drosophila and mice and 
both these organisms presented a lethal phenotype (Rencus-Lazar et al, 2008).  
MMTV insertions into one or more introns of the int6 gene result in synthesis of a C-  
terminally truncated INT6 protein (Int6ΔC). Its synthesis in mouse mammary glands has been 
shown to induce hyperplasia and tumour formation (Mack et al, 2007). Furthermore, Int6ΔC 
can transform human cells in tissue culture, and these transformed cells produce tumours 
when injected into immunodeficient mice (Mack et al, 2007; Mayeur & Hershey, 2002; 
Rasmussen et al, 2001).  
The oncogenic effect of INT6 has been reported although the mechanisms underlying its 
involvement in tumorigenesis remain obscure. Recent data suggest that INT6 plays a direct 
role in the promotion of breast cancer cell proliferation and invasion. The authors have shown 
that overexpression of INT6 acts on one hand as an enhancer of the translation of mRNAs 
coding for factors involved in cancer growth (mRNAs encoding proteins involved in 
coagulation) invasion (taxis and endocytosis) and apoptosis inhibition, and on the other hand 
as an inhibitor of the translation of mRNA coding for factors that control cell division and 
adhesion (Grzmil et al, 2010). 
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Chapter 3 Nonsense mRNA Mediated Decay  
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3. The quality control pathways in ekuaryotes. 
 
After transcription messenger RNAs are likely to accumulate errors. Such fidelity mistakes 
can have fatal effects for single cells or the whole organism. It is thus no surprise that several 
surveillance mechanisms evolved in order to ensure the high reliability of mRNA molecules. 
Currently four basic mRNA surveillance pathways are known: the Nonsense Mediated 
mRNA Decay (NMD); the Nonstop Mediated mRNA Decay (NSD); the No-Go Mediated 
mRNA Decay (NGD); and the Ribosome Extension-Mediated Decay (REMD). In this 
manuscript I will focus on the most studied of these four mechanisms: the NMD. The NMD 
regulates mRNAs containing premature STOP codons (PTC). The NSD as it name indicates 
targets mRNAs with lacking stop codons (Frischmeyer et al, 2002). When mRNAs have 
strong pauses in elongation, and the ribosome remains stalled on the mRNA, it is targeted for 
endonucleolytic cleavage in a process referred to as No-Go decay (NGD) (Doma & Parker, 
2006). Finally when ribosomes inappropriately translate and then terminate within the 3′ UTR 
at least some mRNAs are destabilized in a process referred to as ribosome extension-mediated 
decay (REMD, (Inada & Aiba, 2005)). 
 
3.1. The Nonsense Mediated mRNA Decay. 
 
The NMD pathway has been found in all organisms studied so far, starting from 
Saccharomyces cerevisiae, Caenorhabditis elegans, Arabidopsis thaliana to Homo sapiens 
(Amrani et al, 2004; Brogna, 1999; Gatfield et al, 2003; He et al, 1993; Le Hir et al, 2001b; 
Pulak & Anderson, 1993), for reviews, see (Hentze & Kulozik, 1999; Jacobson & Peltz, 1999; 
Maquat, 1995a; Maquat, 2004). The main function of NMD is to remove mRNAs that contain 
a Premature Termination Codon (PTC) (Fig. 9). The need for a reliable mRNA proofreading 
mechanism seems to be obvious: fast degradation of aberrant mRNAs protects the cells from 
potentially harmful C-terminally truncated proteins that may function in a dominant-negative 
manner. It has been demonstrated that abolishment of the NMD in mice is lethal in an 
embryonic state (Medghalchi et al, 2001). 
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Figure 9. Scheme of a typical NMD target mRNA. The PTC is located in the second exon. 
 
3.2. Sources of NMD substrates 
 
NMD was originally discovered in studies of β-thalassemias where it was triggered by a PTC 
occurring at the position 39 of the β-globin gene. The mRNA encoded by the mutated β-
globin allele was found to be subjected to rapid degradation. During the next 30 years of 
intense studies, the picture of NMD evolved a lot. From a “simple” surveillance pathway it 
changed to a complex and ubiquitous post-transcriptional, translation-dependent mechanism 
of gene expression regulation in eukaryotes. Indeed, the NMD pathway not only degrades 
PTC-containing mRNAs but also influences the expression of transgenes and of dozens of 
endogenous genes during development (we will see below that NMD can also affect mRNAs 
that do not contain PTCs) (Table 3.B.). Still abnormally spliced mRNAs are probably the 
most frequent NMD substrates in cells. Computational analysis of the human EST database 
showed that around 64% of human transcripts are alternatively spliced (AS), and about 45% 
of the transcripts generate at least one splice isoform encoding a PTC (Green et al, 2003) 
(Table 3. A.). Small insertions or deletions which cause frame-shifts, often also generate 
downstream PTCs in the coding region. In addition, PTCs can be generated by transcriptional 
errors and by abnormal pre-mRNA processing. Mutations that alter splicing signals generate 
nonsense mutations, frequently due to the retention of intronic sequences (Mendell & Dietz, 
2001). The Drosophila NMD pathway has critical cellular and developmental roles beyond 
the classical surveillance function of eliminating mutant transcript (Metzstein & Krasnow, 
2006).  
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Aberrant mRNAs subjected to NMD 
 
References 
Aberrant mRNA generated by DNA alterations. 
 
Nonsense 
mutations 
Base substitutions that directly generate PTCs. (Chang & Kan, 
1979) 
Insertions and 
deletions 
Random nucleotide insertions and deletions shift the 
reading frame in two of three cases, resulting in a PTC. 
 
(Culbertson et 
al, 1980) 
Mutations 
changing 
splicing signals 
Mutations leading to aberrant splicing often result in a 
frameshift or in intron-encoded PTCs 
(Mendell & 
Dietz, 2001) 
(Holbrook et al, 
2004) 
Somatic DNA 
rearrangement 
The immunoglobulin superfamily represents a special 
class of NMD targets that undergo very efficient NMD. 
During programmed somatic maturation of the 
immunoglobulin and T-cell receptor genes. Two of three 
rearrangements of the V, D, and J segments result in a 
frameshift, often producing PTCs 
(Carter et al, 
1995; Li & 
Wilkinson, 
1998; 
Weischenfeldt 
et al, 2008) 
Problem at RNA level 
Unproductive 
alternative 
splicing 
45% of alternatively spliced mRNAs are predicted to be 
an NMD target. 
(Green et al, 
2003; Lewis et 
al, 2003; Sayani 
et al, 2008) 
Problem at translation level 
Leaky scanning Observed only in yeast. Ribosomes scan beyond the 
initiator AUG and initiate at a downstream AUG in a 
reading frame with a PTC. 
(Welch & 
Jacobson, 
1999)
1
 
 
 
 
 
 
 
 
 
 
 
 
 
47 
 
 
 
 
 
 
 
 
 
 
 
Physiological mRNAs 
 
References 
Programmed 
translational 
frameshifting 
Programmed + 1 or − 1 frameshifts lead into a PTC, if 
the ribosome fails to shift the reading frame properly. 
(Culbertson et al, 
1980; Lee et al, 
1995) 
mRNAs with 
introns in the 3′ 
UTR 
Observed in yeast and mammals. (Mendell et al, 
2004) 
mRNAs with 
long 3’ UTRs 
observed in yeast, fly, plant and human 
 
(He et al, 2003; 
Kebaara & Atkin, 
2009; Mitrovich 
& Anderson, 
2005; Schwartz et 
al, 2006) 
mRNA of 
transposons and 
retroviruses 
Transcribed 
pseudogenes 
Observed in S.cerevisiae and mammals. 
NMD limits the ‘‘transcriptional noise’’ of supposedly 
non-functional RNAs such as transcribed pseudogenes, ancient 
transposons or mRNA-like non-protein coding RNAs from 
intergenic regions 
(He et al, 2003; 
Kurihara et al, 
2009; LeBlanc & 
Beemon, 2004; 
Mendell et al, 
2004; Mitrovich 
& Anderson, 
2005) 
Bicistronic 
mRNAs 
Observed only in S. cerevisiae. (He et al., 2003) 
 
mRNAs with 
upstream ORFs 
(uORF) 
The termination codon of the uORF is likely to be 
interpreted as PTC, unless the mRNA harbors 
stabilizing elements nearby 
 
(He et al, 2003; 
Mehta et al, 
2006; Mitrovich 
& Anderson, 
2005)  
 
mRNAs 
encoding 
selenoproteins  
 
The UGA is recognized as a PTC at low selenium 
concentrations  
 
(Moriarty et al, 
1998; Sun & 
Maquat, 2002) 
 
Table 3. Features and origins of NMD targets. Modified from Mühlemann 2008 (A) mRNAs presenting aberrant features 
and recognized by the NMD via the PTC. (B) Physiologically regulated mRNAs subjected to NMD, often not presenting any 
PTC, but instead sequences recognized as a PTC.    
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3.3. NMD model 
 
Transcriptomes of Saccharomyces cerevisiae, D. melanogaster and human cells have been 
analysed and have revealed that 3–10% of all mRNAs are affected by NMD. The more 
contemporary view is that NMD has been conserved trough evolution rather as a gene 
expression regulatory mechanism than a degradation pathway for abnormal mRNAs.  
Although NMD and its core factors have evolutionary conserved features the mechanism 
importantly differs among species. I decided to devote this manuscript to mammalian NMD. 
The two main questions to ask about the NMD are: (i) how the cell decides that an mRNA 
should be degraded? and (ii) when is this decision made? 
For a long time the “Holy Grail” in NMD studies was to determine how a cell can distinguish 
between a regular stop codon and a PTC. Over the past decade it became clear that the NMD 
is tightly coupled to (i) splicing and (ii) translation (Carter et al, 1996; Le Hir et al, 2000a; Le 
Hir et al, 2000c; Thermann et al, 1998). During mRNA splicing, a complex called the Exon-
Junction Complex (EJC) is placed at each splice site. The EJC is a 350 kDa multi-protein 
complex containing about ten diverse proteins that remains associated with the mRNA in the 
immediate vicinity of an exon-exon junction (20 - 24nt upstream) after the splicing reaction. 
In normal conditions the EJC is disassembled shortly after nuclear export, however some 
EJC-components remain on the RNA until the ribosome chases them during the first round of 
translation (Dostie & Dreyfuss, 2002). The presence of an EJC 50-55 nt downstream of a 
termination codon triggers NMD (Carter et al, 1996; Thermann et al, 1998).  
Importantly NMD is also clearly linked to translation termination. The distance between the 
termination codon and the poly(A) tail, depending on the length of the 3’ UTR seems to be 
determinant for the classification of a stop codon as premature. If the distance is too short 
NMD is inhibited. 
 
3.3.1 The EJC-dependent model of NMD. 
 
The core EJC factors consist of: the heterodimer MAGOH–Y14, the DEAD-box RNA 
helicase eIF4AIII and MLN51 (Le Hir et al, 2000b). In association with an mRNA molecule, 
the EJC complex has been shown to contain also important NMD factors such as UPF2 and 
UPF3b (Le Hir et al, 2001b). Up to now more than a dozen proteins have been identified as 
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components of the EJC, including splicing coactivators and alternative splicing factors 
(SRm160, RNPS1 and Pinin) and mRNA export proteins (UAP56, REF/Aly and NXF1/TAP: 
p15) (Kataoka et al, 2000; Le Hir et al, 2001a; Le Hir et al, 2000a; Lykke-Andersen et al, 
2000).  A conserved domain in UPF3a and UPF3b associates with Y14 and RNPS1, and this 
interaction is essential for NMD. Thus, the EJC has been proposed to provide a direct link 
between splicing and NMD by serving as the anchor site for UPF2 and UPF3 (Le Hir et al, 
2001b).   
According to the EJC-dependent model of NMD, normal termination codons can only be 
found in the last exon of an mRNA molecule. This also means (and has been experimentally 
confirmed) that RNAs originating from intronless genes (and thus devoid of EJC) are immune 
to at least this mechanism of NMD induction (Maquat & Li, 2001).  
However the group of Lykke-Andersen recently reported that the introduction of a PTC in an 
intron-deprived Glutathione Peroxidase 1 (GPx1) mRNA triggered NMD, although the decay 
observed was less efficient than when a GPx1 mRNA containing an intron has been used. 
Moreover the study failed to identify natural human intron-less mRNAs that are subjected to 
NMD. Thus the statement that naturally intron-less genes are immune to NMD seems to be 
correct at least for a vast majority of examined genes (Singh et al, 2008). 
 
3.3.2 The faux 3’ UTR model.  
 
The second model of PTC detection proposed was first discovered in yeast. Recently it has 
been found that mammalian mRNAs regulated by NMD can be also eliminated due to a signal 
coming from the translation termination. As mentioned in the previous paragraph 
mutated/abnormal mRNAs that contain a PTC tend to have longer 3’UTRs than their wild 
type analogs. A longer 3’UTR results in turn in the stimulation of one of the core NMD 
factors (UPF1) and in the reduction of the efficiency of translation termination (Rodriguez-
Gabriel et al, 2006). This discovery suggested that the important distinction between normal 
and premature terminations might simply rely on the distance between the stop codon and the 
3’ end of the mRNA. This model – called the faux 3’ UTR model – claims that efficient 
termination requires an interaction with factors associated with the 3’ UTR. The original faux 
3’ UTR model proposed that inefficient termination is due to lack of interaction between the 
terminating ribosome and PABPC (Poly(A) Binding Protein Complex) (Amrani et al, 2004). 
Further studies indicated that the distinction of a PTC from a normal stop codon depends on 
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its distance from the poly(A) tail and upon the competition between UPF1 and PABP for 
binding to eRF3 on the terminating ribosome. 
In agreement with the faux 3’ UTR model, any extension or shortening of the distance 
between PTCs and the poly(A) tail affected NMD in different experimental systems (Behm-
Ansmant et al, 2007; Buhler et al, 2006; Eberle et al, 2008). Moreover PTC-bearing mRNA 
that lack a poly(A) tail are not subject to NMD, and depletion of PABPC strongly inhibits 
NMD in Drosophila S2 cells, suggesting that both the poly(A) tail and PABPC are crucial for 
NMD (Behm-Ansmant et al, 2007). 
 
 
3.3.3 A unified model? 
 
Despite the intense study of NMD, the PTC-recognition mechanism remains incomplete. It is 
interesting to imagine a coherent PTC-recognition model (Fig.10). What emerges is the 
multitude of important signals influencing the NMD. Those signals might be for instance the 
nature of the stop codons, the nucleotide immediately following the stop codon, and the 
sequences, length, and associated proteins of 3′UTR and ending with specific factors 
triggering the NMD e.g., EJC, PABP; the list is long and continues growing. These features 
might be working in opposing or orchestra fashions (e.g., inhibit or stimulate normal or 
aberrant termination). One can suppose that depending on the transcript, cell conditions, 
model organism, and/or experimental setup, some of these features may appear to be more 
important than others. 
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Figure 10. The unified 3’ UTR model for NMD. NMD is mainly determined by the flanking 3 UTR. PABP plays an 
antagonistic role in NMD. NMD is elicited if the PTC is placed in a long distance from the poly(A) tail. When termination 
occurs near the poly(A) tail, PABP prevents the recruitment of UPF1,and so preventing the NMD. The presence of a 
downstream intron deposits an EJC which can further stimulate the recruitment of UPF proteins and NMD execution. 
 
 
 
 
 
3.4. The Pioneer Translation Round – to degrade or not to degrade? 
 
In mammalian cells the fate of an mRNA molecule is sealed during the so-called Pioneer 
Round of Translation (Ishigaki et al, 2001). During this first ribosomal scanning aberrant 
transcripts are detected according to the features presented previously.  The NMD machinery 
has been shown to target mRNA bound by the Cap-Binding Proteins (CBP80–CBP20) 
(Ishigaki et al, 2001; Lejeune et al, 2002). 
The initiation of the pioneer round engages at least one ribosome (this depends on the length 
of the translational open reading frame and general initiation efficiency) (Isken et al, 2008). 
The pioneer round of translation occurs before the bulk translation and involves mRNA that is 
bound by the cap-binding protein (CBC a heterodimer of CBP80 and CBP20) (Fig. 10). In 
higher eukaryotes intron containing pre-mRNA involves the deposition of an EJC upstream of 
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each exon-exon junction which along with other NMD factors and the poly(A) tail are 
required for NMD.  After the pre-scanning of mRNA, the pioneer round translation complex 
is transformed into a steady-state initiation complex. Remarkably, the NMD factors along 
with EJC components are removed and so the RNP is reconfigured allowing the eIF4E 
binding to the cap (Lejeune et al, 2002). These rearrangements support the idea that NMD is 
triggered by the pioneer round of translation. 
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3.5 NMD Factors  
 
The discovery of NMD factors started in S. cerevisiae and C. elegans (Culbertson et al, 1980; 
Hodgkin et al, 1989) and homologs were found later in higher eukaryotes. One can 
distinguish three main trans-acting factors, the so called Up-Frameshift (UPFs) proteins 
(UPF1, UPF2 and UPF3 which exists in two isoforms UPF3a and UPF3b also termed 
UPF3X). A very important class of proteins regulates the function of the UPFs, the 
Suppressor of Morphological defects on Genitalia (SMG) proteins (SMG-1, SMG-5, SMG-6, 
and SMG-7). They are known to mediate the phosphorylation and dephosphorylation cycle of 
UPF1. 
 
3.5.1 UPFs 
 
In mammalian cells, UPF proteins are very abundant, up to millions of copies per cell can be 
detected, much more than the protein levels in budding yeast (Culbertson & Neeno-Eckwall, 
2005). Interestingly UPF1 is almost 5-10 times more abundant than UPF2 and UPF3. This 
does not only suggests a pivotal role in the NMD but supports the data of many studies in 
which it was shown that UPF1 has additional non-NMD roles. Those are independent of 
UPF2 and UPF3 (Azzalin & Lingner, 2006; Isken et al, 2008; Kaygun & Marzluff, 2005a). 
 
3.5.2 UPF1 
 
The UPF1 (also known as RENT1 in human) is a RNA binding protein with, ATPase-
dependent, helicase activity (Czaplinski et al, 1995). Both in yeast and human UPF1 
associates with the ribosome via the interaction with the eukaryotic translation release factors 
eRF1 and eRF3 during premature translation termination (Czaplinski et al, 1995; Ivanov et al, 
2008; Kashima et al, 2006; Weng et al, 1998). UPF1 has two separate functional domains: a 
cysteine-histidine rich (CH) domain at the N terminus and an ATPase/helicase domain at the 
C terminus.  
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3.5.3 UPF2 
 
UPF2 contains three continuous domains which resemble middle domain of the eukaryotic 
initiation factor 4G motifs (MIF4G) (Rehwinkel et al, 2005b). MIF4G domains are found in 
several proteins involved in mRNA processing and translation, such as eIF4G and CBP80 
(Marcotrigiano et al, 2001; Mazza et al, 2001). 
 
3.5.4. UPF3 
 
In humans two UPF3 homologues are known, UPF3a and UPF3b (Lykke-Andersen et al, 
2000). Both proteins contain a putative RNA recognition motif (RRM) at the N terminus, 
which is involved in RNA binding.  
A number of observations indicate that UPF1, UPF2 and UPF3 form a complex 
(He et al, 1997; Weng et al, 1996).  In human cells, the UPFs form a trimeric complex where 
UPF3 contacts via its N-terminal region UPF2, which in turn interacts with the CH domain of 
UPF1 (Chamieh et al, 2008; Kadlec et al, 2006; Kadlec et al, 2004; Lykke-Andersen et al, 
2000; Mendell et al, 2000). 
 
3.5.5 SMGS 
 
As mentioned previously the SMG proteins are regulatory proteins. During NMD, UPF1 
undergoes sequential dephosphorylations and phosphorylations. The phosporylation state of 
UPF1 is critical for proper NMD function in metazoan and human cells (Grimson et al, 2004; 
Isken & Maquat, 2008; Ohnishi et al, 2003).  
SMG1 is a phoshatidylinositol kinase-related kinase that phosphorylates UPF1 and activates it 
for NMD (Grimson et al, 2004; Yamashita et al, 2001). SMG5 and SMG7 are involved in the 
dephosphorylation of UPF1 and inhibit the UPF1-driven NMD (Anders et al, 2003; Chiu et al, 
2004; Fukuhara et al, 2005; Ohnishi et al, 2003). Two additional proteins, SMG-8 and SMG-
9, have also been shown to bind SMG1 (Yamashita et al, 2009). Both of them suppress the 
kinase activity of SMG1 and are components of the NMD inducing complex. The so called 
SURF complex contains the NMD factors, SMG1, UPF1, and the release factor eRF1 and 
eRF3 (Kashima et al, 2006; Yamashita et al, 2009). SMG-8 also seems to play an important 
role in the interaction between the complex and EJC (Yamashita et al, 2009). 
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3.6 The Core NMD Machinery  
 
Following PTC recognition a cascade of events triggers fast degradation of aberrant mRNA. 
The process starts by the joining of UPF3 to the EJC in the nucleus.   
During the pioneer round of translation it comes to the formation of the SMG1-eRF1-eRF3-
UPF1 (SURF) complex with the mRNA. SURF is recruited by the ribosome stalled on a PTC 
containing mRNA. Then UPF2 bridges the interaction between the ribosomal SURF (via 
UPF1) and the downstream EJC (via UPF3).In this complex SMG1 phosphorylates UPF1 and 
elicits the dissociation of the two release factors (eRF1 and eRF3). As a result, a complex 
containing the EJC, UPF2, UPF3, phosphorylated UPF1 and SMG1, triggers the inhibition of 
translation and degradation of the mRNA.   
In parallel with mRNA degradation, UPF1 is dephosphorylated by SMG5 and PP2A and can 
be recycled (Chiu et al, 2004; Ohnishi et al, 2003).  
 
3.6.1 Alternative NMD pathways. 
 
It has been reported that there are important variations from the “standard” NMD mechanism.  
The linear model of mammalian NMD is likely oversimplified because examples have been 
described where NMD can be UPF2 or UPF3b independent, or even occur independently of 
splicing (Buhler et al, 2006; Chan et al, 2007; Gehring et al, 2005). 
 
3.6.1.1 The INT6-dependent NMD. 
In order to complete the current NMD-core model it has to be mentioned that not all NMD 
targets require exactly the same set of factors. Additionally to the UPFs some other factors 
and alternative NMD pathways have been identified. In a previous work of our laboratory it 
has been established that INT6 was able to interact with both UPF1 and UPF2 (Morris et al, 
2007). Moreover in INT6 silenced cells NMD was inhibited. This observation along with the 
fact that INT6 was able to bind CBP80 was in agreement with the fact that INT6 is not 
necessary for steady translation but rather for a pre-translational proofreading process. 
Although this possibility needs to be further investigated its interaction with the CBP80 
subunit of the CAP Binding Complex would support this notion (Morris et al, 2007). Such an 
interaction could facilitate further loading of the remaining eIF3 complex and lead to the 
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initiation of the pioneer round of translation. It was shown that the composition of eIF3 is 
highly dynamic so it does not seem aberrant that a specific sub-complex of eIF3 might 
function in the pioneer round of translation. The formation of an INT6-mediated complex can 
lead to lead to different patterns. The first possibility is to complete translation normally and 
replace the EJCs and the CBC by eIF4E (Chiu et al, 2004; Lejeune et al, 2002). The 
remodelled mRNP can then be routed towards active translation which might use an eIF3 
complex lacking INT6. Alternatively, after detection of a premature termination signal the 
SURF complex is recruited triggering SMG1-mediated phosphorylation of UPF1. This event 
leads to translation initiation inhibition and allows the recruitment of degradation factors such 
as DCP1, XRN1 and EXOSC2 (Isken et al, 2008; Lejeune et al, 2003b). 
 
3.7 The way to decay. 
 
The degradation can pursue a “canonical” mRNA decay pathway that destroys “normal” 
mRNAs by a 3’-5’ or 5’-3’ decay (He & Jacobson, 2001; Lejeune et al, 2003b; Sheth & 
Parker, 2003). More recent studies have reported that in D. melanogaster and human cells, 
NMD substrates appear to be degraded by an alternative pathway, involving an 
endonucleolytic cleavage (Behm-Ansmant et al, 2007; Eberle et al, 2009; Gatfield & 
Izaurralde, 2004).  
 
3.7.1 The 3’ – 5’ decay.   
 
Eukaryotic mRNAs have two stability elements, the 7–methylguanosine cap at the 5’ end and 
poly(A) tail at the 3’ end. Deadenylation typically precedes the breakdown of the mRNA. In 
higher eukaryotes, the Poly(A) Ribonuclease (PARN) is the main poly(A) nuclease of 5’ 
capped mRNA (Garneau et al, 2007). Following the shortening of the poly(A) tail, mRNAs 
are the target of the cytoplasmic exosome. This 3’-5’ exonucleolytic complex is composed of 
10-12 subunits and associated with the Ski complex (consisting of Ski2, Ski3, Ski7 and Ski8) 
(Garneau et al, 2007; Ibrahim et al, 2008; Schmid & Jensen, 2008).  
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3.7.2 The 5’ – 3’ decay.  
 
Meanwhile, the 5’ends are decapped by Dcp1 and Dcp2 enzymes. Decapped mRNAs are 
subjected to 5’-3’ degradation by the exoribonuclease XRN1 (Anderson & Parker, 1998; 
Decker & Parker, 2002; Lejeune et al, 2003a; Mangus et al, 2003). The rapid decapping of 
PTC-containing mRNAs is probably mediated by the interaction of UPF1 with Dcp1:Dcp2 
(Lykke-Andersen, 2002). 
 
3.7.3 Endonucleolytic Cleavage 
 
Evidence of the involvement of the endonucleolytic cleavage was reported already in the No-
Go mRNA decay (NGD) in S. cerevisiae where a stem loop prevents translation elongation 
and also triggers mRNA decay (Doma & Parker, 2006). In human cells the endonucleolytic 
cleavage has been reported to occur at multiple sites close to a PTC. Surprisingly the cleavage 
reaction can take place both before and after the stop codon. Studies of D. melanogaster and 
human cells reveal that this cleavage depends on a functional SMG6 protein (Eberle et al, 
2009; Huntzinger et al, 2008). This last observation suggests a possible link between the 
stalling of the ribosome and the SMG6-dependent endonucleolytic cleavage.  
 
In summary, NMD substrates are likely to be degraded by a number of pathways, requiring 
both endo- and exonucleases (Fig.12). 
 
59 
 
 
Figure12.Three possible pathways leading to RNA degradation. Adapted from (Eberle et al, 2009) 
 
 
3.8 Localization of mRNAs degradation.  
Can translation take place in the nucleus? Very controversial studies. 
 
The localization of mRNA degradation is a subject of animated discussion. Some studies in 
human cells indicate that NMD occurs while the mRNA is still associated with the nuclear 
cap binding complex (CBC), but not with eIF4E. Early studies of NMD of the β-glogin 
mRNA and Triosephosphate Isomerase (TPI) mRNA in human cells indicated that NMD 
might target mRNAs still associated with the nucleus. These studies reported that there was 
no change in the stability of cytoplasmic mRNAs containing or not nonsense mutations 
(Baserga & Benz, 1992; Cheng & Maquat, 1993). Further studies with human TPI mRNA 
also reported that nucleus associated NMD takes place after splicing (Belgrader et al, 1994; 
Cheng et al, 1994). It appears that the level of nucleus-associated mRNA was always reduced 
to almost the same amount as the cytoplasmic mRNA containing a PTC, in human cells 
(Maquat, 1995b). Furthermore, several studies reported that there is no obvious difference in 
stability between mRNA carrying PTCs and the corresponding wild-type mRNA, in spite of 
the low steady state level of the PTC-containing mRNAs (Baserga & Benz, 1992; Cheng & 
Maquat, 1993). These observations have led to a suggestion that the PTC-containing 
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transcripts are degraded in the pioneer round translation while they are still associated with 
the nucleus (Hentze & Kulozik, 1999). It was also proposed that mRNA escaping this first 
round of translation escape NMD as well. Nucleus associated NMD in mammalian cells 
presents a paradox, because it is believed that only cytoplasmic ribosomes recognize and scan 
the open reading frames. 
3.8.1 Cytoplasmic NMD. 
A great amount of studies was performed demonstrating that it takes place in particular 
cytoplasmic compartments known as Processing Bodies (P-bodies). These structures include 
various proteins intervening in degradation as the decapping enzymes DCP1, DCP2 and also 
exonucleases as XRN1.  (Couttet & Grange, 2004; Rehwinkel et al, 2005a). Recently it has 
been shown that degradation can still occur if formation of the processing bodies is inhibited. 
(Stalder & Muhlemann, 2009). This suggests that P-bodies and their components function as 
enhancer for correct and efficient NMD but are not absolutely indispensible for the process to 
occur.   
 
3.8.1.1 Processing bodies (P-bodies) 
Initial studies on the subcellular localization of the main 5’ to 3’ exoribonuclease involved in 
mRNA decay in eukaryotic cells (XRN1), revealed that it was localized in small granular 
structures enriched in cytoplasmic foci (Bashkirov et al, 1997) (Fig.13). However, the 
biological significance of this discovery was only appreciated some years later when the 
decapping enzyme DCP2 and some of its cofactors were also shown to co-localize with 
XRN1 in the same cytoplasmic foci (Ingelfinger et al, 2002; van Dijk et al, 2002). Due to this 
kind of protein component (decapping and 5’ to 3’ mRNA decay machineries), these 
DCP/XRN1 cytoplasmic foci were suspected to function in cytoplasmic mRNA decay and 
were referred as processing (p)-bodies, DCP bodies or mRNA-decay bodies. Interestingly, 
similar cytoplasmic foci were discovered at the same time by using a serum that recognized 
GW182, a human protein rich in GW (Gly-Thr) repeats of 182-kDa with unknown function 
(Figure 47) (Eystathioy et al, 2002). Only one year later it was demonstrated that GW182, 
DCP2 and XRN1 were present in the same cytoplasmic structure (Eystathioy et al, 2003). An 
important point for P-bodies formation was their dependency on RNA further suggesting that 
these cytoplasmic foci could be a place for mRNA decay (Andrei et al, 2005; Cougot et al, 
2004; Teixeira et al, 2005).  
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3.8.1.2 P-bodies and mRNA Surveillance 
P-bodies have been shown to contain proteins involved in the NMD such as UPF1, UPF2, 
UPF3, SMG-5 and SMG-7 (Sheth & Parker, 2006; Unterholzner & Izaurralde, 2004). There 
are several lines of evidence showing that NMD-targeted mRNAs along with NMD factors 
are shipped to P-bodies both in yeast and humans cells (Durand et al, 2007b; Sheth & Parker, 
2006). However, more recent studies demonstrate that the formation of P-bodies is not 
essential for NMD at least in human cells (Stalder & Muhlemann, 2009). Nevertheless, 
downstream steps following NMD involve deadenylation, decapping and the 5’ to 3’ 
degradation (Chen & Shyu, 1995; Couttet et al, 1997; Lejeune et al, 2003b). Since proteins 
like DCP1 and 2, Xrn-1 are essential components of P-bodies it could suggest that they are 
eventually involved at the end of the NMD process.   
 
Figure 13. P-bodies in Hela cells. The P-bodies (visualized by red spots) have been observed with a confocal upright 
microscope. One of the P-bodies components contains and RFP-tag (DCP1-RFP) and is transitionally overexpressed.  
 
3.9 The ability to escape NMD. 
According to the present vision of NMD, a PTC-containing transcript should be subjected to 
NMD recognition and further degradation, but what would be a rule without any exception? 
Few cases were reported in which NMD seem not to detect mutated transcripts. This may 
occur when (i) the PTC locates in the last exon of an mRNA (Perrin-Vidoz et al, 2002) (ii) at 
the beginning of the coding sequence (so that translation re-initiation can be induced) (Puel et 
al, 2006), or (iii) when the PTC is absent because of exon skipping event (Disset et al, 2006; 
Zetoune et al, 2008). 
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Chapter 4 Histones – from discovery to 
functional insights.  
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4. The discovery of histones; at the origins of the chromatin research. 
 
Histones, which were discovered at the end of the 19th century, are chief proteins around 
which DNA is packaged in the cell nucleus. They are thus essential components of eukaryotic 
chromosomes. In metazoans, they are encoded by the so-called replication-dependent histone 
genes. The biogenesis of histones is tightly coupled to DNA replication. DNA replication is 
controlled in the context of the cell cycle. As the cell grows and divides, it progresses through 
stages in the cell cycle; DNA replication occurs during the synthesis phase (S phase).The 
stoichiometric manner of control is extremely important because an excess of histones is 
highly toxic for the cell. Since histones present a highly basic character any excess is 
extremely hazardous resulting in non-specific binding to nucleic acids and non-nucleosomal 
aggregate forming. Therefore, a strict cell cycle-regulation of the critical factors involved in 
histone expression ensures exclusive S phase expression. 
4.1. The history of chromatin research. 
 
The history of chromatin and histone research is a long one, starting with Walter Flemming’s 
original studies of mitosis performed in the late 19
th
 century (Fig. 14). In 1880 this remarkable 
researcher proposed the name “chromatin” explaining that: “...in view of its refractile nature, 
its reactions, and above all its affinity to dyes is a substance which I have named chromatin.”  
Thus, the term chromatin has been derived from the Greek "khroma" meaning coloured and 
“soma" meaning body, based on its stain ability with basic dyes. 
Later biochemical studies followed and two students of E. Hoppe-Seyler, F.Miescher and 
Albrecht Kossel, performed crucial work for the characterization of chromatin components. In 
1871 Miescher described a strong phosphorus-rich acid and baptised it “nuclein”. In 1884 
Albrecht Kossel identified histones in acidic extracts from avian erythrocyte nuclei (Olins & 
Olins, 2003). 
The impact of Miescher’s work was overshadowed by the more hyped discovery of the rules 
of genetic inheritance by Austrian monk Gregor Mendel and the theory of evolution by 
British scientist Charles Darwin. More and more progress was done in the field of genetics. In 
1900 Hugo Marie de Vries rediscovered Mendel’s laws, introduced the concept of genes and 
the term "mutation". He also developed the mutation theory of evolution (Lenay, 2000), 
followed by the development of the gene theory and principles of linkage by T. H. Morgan in 
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1910 (Olins & Olins, 2003). While these revolutionary discoveries were made in the field of 
genetics, progress in the adjacent field of chromatin and histones remained in the shade of 
genetics. Indeed, histones were still considered to be the bearers of genetic information until 
the early 40s. Then another big achievement was made by Franklin Griffith in 1928 (Olins & 
Olins, 2003) by describing the principle of transformation which led Oswald Avery, Colin 
Macleod and Maclyn McCarty in 1944 (Avery et al, 1944) to demonstrate that DNA was 
actually the molecule encoding the genetic information. The early discovery of polytene 
chromosomes in Drosophila and gene localization studies inspired D. Mazia to use proteases 
and nucleases to study salivary gland polytene chromosomes (Mazia & Jaeger, 1939). The use 
of nucleases in particular revolutionized the chromatin field. Then came the famous April 
1953 issue of Nature which contained the historic three papers by Watson & Crick, Wilkins, 
Stokes & Wilson and Franklin & Gosling describing the structure of the DNA double helix. 
This “Rosetta stone” discovery lay down the foundations of modern molecular biology. 
Solving the complementary DNA structure allowed the understanding of the still abstract 
genetics and the function deprived chromatin study. In 1959 G. Zubay`s laboratory used the 
first time biophysical approaches to study the chromatin structure preparing soluble 
chromatin. In the meantime, histone proteins were fractionated by the group of E. Johns. 
The next big step was the development of electron micrography, introduced in the chromatin 
field in 1970 by H. Davies who had observed 30 nm chromatin threads in chicken erythrocyte 
nuclei. Similar fibres were observed subsequently in purified chromatin preparations by the 
group of Klug in 1976. The “beads on the thread” were visualized by two independent groups: 
first Olins and Olins in 1974 who named them “v (nu) bodies”, then C.L.F. Woodcock in 
1976 (Olins & Olins, 1974; Woodcock et al, 1976).  
In 1974 R. Kornberg and J. Thomas postulated a model for the structure of  chromatin, 
describing it as a repeat of ~200 base pairs of DNA in complex with an octamer of core 
histone, itself made of a tetramer of histones H3 and H4 and two dimers of histones H2A and 
H2B. This chromatin subunit was christened “Nucleosome” by P. Chambon in 1975 (Oudet et 
al., 1975). Linker histones were subsequently proposed to link the nucleosome core particles 
in chromatin (Kornberg & Thomas, 1974; Noll & Kornberg, 1977).  
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Figure 14. Diagram representing the milestones in chromatin studies. From (Olins & Olins, 2003) 
 
The concept of the organization of DNA and histones in nucleosomes was derived from X-ray 
crystallography studies of the histone octamer and the core particle by the groups of E.N. 
Moudrianakis (Arents et al, 1991) and T.J. Richmond (Luger et al, 1997), respectively. 
However, there have been many controversial reports about the precise location of linker 
histones in chromatin (Kornberg & Lorch, 1999; Rando & Chang, 2009).  
In vitro studies of the chromatin fibre have led to the proposal of two main, competing models 
of the higher order (30 nm scale) structure of chromatin, namely the “zigzag model” 
(Williams et al, 1986; Worcel et al, 1981) and the “solenoid model” (Dorigo et al, 2003). 
Despite many refined and compelling studies, a consensus has yet to emerge. 
 
4.2. Chromatin and Core histones 
In human cells roughly two meters of DNA (6 x 109 bp) have to be compacted in a micron 
sized (5-10μm) nucleus (Fig. 15) and at the same time must be rapidly accessible to  allow the 
various transactions – replication, transcription, repair and recombination – that affect the 
DNA of a cell to be efficiently mediated. The structure of chromatin and its dynamic re-
organization can thereby potentially influences all the functions of the genome. 
In the nuclear genome, within chromatin the DNA molecule is bound tightly to an almost 
equal mass of histones, so that about 60 million histone molecules may be found per human 
cell. Histones are small 12-20 kD proteins that possess an open, unfolded structure and 
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attached to the DNA molecule by ionic linkages. Up to now 5 major histone classes have been 
identified. Four of them fall under the core histone category (H2A, H2B, H3, H4) and form 
the nucleosome core particle, while the fifth class, linker histones (LH; H1/H5) regroups 
proteins that connect nucleosomes one to another. Despite the H1 linker histone, core histones 
are deeply evolutionarily conserved and can be found in the nuclei of Euryarchaeota but not in 
Bacteria. Their conserved character emphasizes the important role they play in the biology of 
the nucleus. However the conservation of core histone sequences is not uniform and mainly 
affects the main, central domain, which contains a “histone fold motif” averaging about 65-70 
amino acids. This motif consists of three alpha helices connected by short loops and is 
responsible for DNA-histone and histone-histone interactions (Arents & Moudrianakis, 1995; 
Bolognese et al, 2000).  The two termini extend outside the nucleosome core (Fischle et al, 
2003). Both the C-terminal and the N-terminal histone tail are the major sites of post-
translational modifications affecting histones, and those in turn play a crucial role in the 
regulation of gene expression. More about this subject will be described later in this 
manuscript. 
 
Figure 15 Organization of eukaryotic chromatin fibers. The fundamental unit of chromatin is defined as nucleosome that 
forms the “beads-on-a-string” chromatin structure. Internucleosomal interactions, linker histones and non-histone proteins 
mediate the further condensation of chromatin into 30nm fibers and higher order structures. Adapted from (Hansen, 2002)  
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4.3. The nucleosome. 
 
H2A and H2B form two heterodimers flanking a heterotetramer composed of H3 and H4. 
Together they make up an octamer around which 147 bp ± 1bp of DNA is wrapped, forming 
the nucleosome core particle (NCP) – the basic particle of chromatin (Fig. 16). Adjacent 
nucleosomes are connected one to another by a double-stranded linker DNA (20-80bp). The 
average size of the linker DNA segment varies depending on species and tissue. This linker 
DNA is stabilized by the fifth histone, H1. Different models of H1 binding are adopted. The 
most common is representing the “H1siting” on the nucleosome core and binding the DNA 
entry/exit points, thus protecting around 20 bp of linker DNA. Former studies have shown 
that LHs exhibit a general preference for AT-rich DNA.  The globular domain can interact 
with the minor groove located in the centre of each nucleosome. The LH is believed to be 
responsible for the 30 nm chromatin fibre formation. 
 
 
 
Figure 16 Model of a nucleosome: From: (Wolffe & Hayes, 1999) 
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4.3.1. Histone Chaperones. 
It has been shown that correct DNA condensation is ensured by interactions between H1 and 
so called “histone chaperones” which modify chromatin dynamics in an ATP-dependent 
manner (Table 4). The one responsible for correct H3-H4 tetramers deposition on the DNA is 
called Chromatin Assembly Factor 1 (CAF-1). Targeting the complex to the newly replicated 
DNA is enhanced by the Proliferating Cell Nuclear Antigen (PCNA), a ring-shaped protein 
known to encircle DNA and to serve as a processivity factor for the DNA polymerase II 
(Akey & Luger, 2003; Elsasser & D'Arcy, 2011; Gunjan et al, 2005) The next factor required 
for efficient nucleosome assembly is the Replication-Coupled Assembly Factor (RCAF), 
which comprises the Antisilencing Function 1 protein (ASF1) and acetylated (H3–H4)2 
tetramers.  An additional histone chaperone is required for deposition of two H2A–H2B 
dimers, and this role is thought to be fulfilled by Nucleosome Assembly Protein-1 (NAP-1) 
(Campos & Reinberg, 2010; Green et al, 2005; Mello et al, 2002; Tagami et al, 2004; Tyler et 
al, 1999; Tyler et al, 2001). 
The regulated deposition of histones onto DNA arises not only during the replication of DNA in S 
phase, but also during DNA damage outside S phase or in non- dividing cells undergoing gene 
expression. Most organisms encode histone variants that are constitutively expressed in small 
quantities during the cell cycle. These variants are incorporated in the nucleosome by distinct 
pathways. In higher eukaryotes, the Histone Regulatory Homolog A (HIRA), is  known to promote the 
assembly of histone H3.3 into chromatin independently of DNA replication .Similar to replication 
dependent nucleosome assembly mediated by CAF-1, Asf1 is proposed to deliver H3–H4 to HIRA for 
subsequent nucleosome assembly (Li et al, 2011) 
Histone 
chaperone 
Replication 
coupled (RC) 
Replication 
independent (RI) 
Asf1 + + 
CAF-1 + + 
RCAF + _ 
NAP-1 + _ 
HIRA(HIR1) _ + 
Daxx _ + 
Table 4. Main histone chaperones, modified from (Li et al, 2011) 
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4.3.2. Histone replacement variants 
 
As mentioned before in addition to each of the five major histone types (H1, H2A, H2B, H3 
and H4), whose genes are expressed during the S phase of the cell cycle, some minor variant 
forms have been discovered over the years of chromatin studies (Table 5). Many of the 
replacement variants are replication-independent. They are classified on a structural basis into 
homomorphous and heteromorphous families, depending on the extent of their amino acid 
sequence departure from the main canonical isoforms. The homomorphous variants involve 
only a few amino acid changes (i.e. H2A.1 and H2A.2; H3.1, H3.2 and H3.3) whilst 
heteromorphous variants involve changes that affect larger portions of the histone molecule 
[i.e. H2A.X, H2A.Z, macroH2A (mH2A), H2A Barr body-deficient (H2A.Bbd) and 
centromeric protein A (CENP-A) (Ausio, 2006). 
 
Core histone variants with potential unique functions 
 Variant Variant 
species 
Mutant phenotype Function 
CENP-A Ubiquitous Lethal (mouse 
embryos) 
Kinetochore assembly 
MacroH2A Vertebrate Severe malformations 
in the brain 
(Zebrafish) 
X-chromosome inactivation; gene 
expression  
H2A-Bbd Vertebrate Not Determined Transcriptional Activation 
H2A.Z Ubiquitous Lethal (mouse, flies, 
Tetrahymena) 
Unclear; altered higher-order 
chromatin structure  
H2AX Ubiquitous  Tumor formation in 
mice T- and B-cell 
lymphomas. Reduced 
fecundity (females); 
sterility (males) 
DNA 
repair/recombination/transcription 
repression 
H3.3 Ubiquitous Embryonicly lethal Transcription 
 
Table 5 Histone variants  Modified from (Kamakaka & Biggins, 2005) 
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4.3.3. Modification of histone proteins 
 
It is well known that both canonical histones and their variants are often subjected to specific 
Post Transcriptional Modifications (PTMs) i.e. acetylation, methylation, phosphorylation, 
ubiquitination and poly-ADP-ribosylation (Fig. 17). The evolution from the theory that 
histones provide only a backbone for DNA to the discovery of the PTMs affecting the 
deciphering of DNA information surely revolutionized the way chromatin is perceived. Since 
histone modifications were found to be implicated in a plethora of cellular and developmental 
processes as well as in diseases the field has developed incredibly fast in the last few years 
(Bodai et al, 2003; Cress & Seto, 2000).  Histone modifications as well as chromatin 
remodelling facilitate the binding of transcription factors to gene regulatory regions, which 
allows assembling of the RNA polymerase complex to activate transcription reviewed in 
(Felsenfeld & Groudine, 2003; Narlikar et al, 2002)). 
The combinations of PTMs determine the so-called ‘‘histone code’’ (Fischle et al, 2003).This 
histone code dictates, on a global scale, the state of the chromatin (euchromatin versus 
heterochromatin) and, on a smaller scale, the transcriptional activity of specific genes 
(Bradbury, 1992; Jenuwein & Allis, 2001; Peterson & Laniel, 2004).  
 
 
 
 
Figure 17. Post-translational modifications of the core histones.The colored shapes represent known post-translational 
modifications of the core histones. The histone tails can be methylated at lysines and arginines (green pentagons), 
phosphorylated at serines or threonines (yellow circles), ubiquitylated (blue stars) and acetylated (red triangles) at lysines 
(Peterson & Laniel, 2004). 
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4.4. Gene expression 
 
In living organisms five major steps of gene expression can be distinguished. These are the 
transcription of DNA into pre-mRNA, maturation of pre-mRNA, mRNA translation, mRNA 
degradation and finally protein degradation. Even though similarities in the main parts of all 
these mechanisms can be found between different organisms and their various genes, it is 
clear that each of them is made up of an individually controlled cascade of events.   
 
4.4.1. The origin of histone genes.   
Classically one speaks about a unique histone gene family present only in metazoans. As 
mentioned before this statement lacks precision because these histone genes were identified as 
well in organisms which classification is not completely clear such as Volvox carteri and 
Chlamydomonas reinhardtii. Previous estimation of late evolutionary emergence of histone 
genes turns out to be incorrect. Samuelssons studies shed new light on this issue. In 2008 they 
discovered several components of the 3’histone mRNA translational machinery in numerous 
protozoa such as Dictyostelium, alveolates, Trypanosoma, and Trichomonas. After astute 
analysis it turned out   that these organisms present a potential stem–loop structure in the 3′ 
UTR (Dávila López & Samuelsson, 2008). 
Moreover their data highlight the fact that some histone mRNAs, in meta-, and protozoa, 
possess a poly(A) tail as well as a 3’ SL. This makes up an exciting and unique gene 
regulation model in which the processing of the 3’ end can generate either a poly(A) mRNA 
or the one characteristic of replication-dependent histone mRNAs with a SL-mediated 
processing of the 3’end.    
Taken together the specific SL and its binding protein SLBP appeared rather early in the 
eukaryotic evolution process. Probably SLBP was even involved in histone mRNA 
metabolism regulation, which could include pre-mRNA processing. Although this specificity 
was lost in numerous species several representative remnants are known in most phyla. In 
metazoans SLBP acquired additional functions regarding the histone gene expression (Dávila 
López & Samuelsson, 2008; Marzluff et al, 2008). 
 
4.4.2. Coordinate Regulation of Histone Genes.  
One can define the canonical histone proteins, which make up the vast majority of the 
histones found in a cell at any given time, as those encoded by a family of replication-
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dependent histone genes. These genes code for all the four core histones (H2A, H2B, H3 and 
H4) and for the linker histone H1.  
 
4.4.2.1. Organization of canonical histone genes. 
 
In all metazoans each of the five classes of canonical histones is encoded by between 
10 and 20 different genes (this number varies depending on the canonical histone and the 
species). These canonical histone genes present the unusual feature that they are clustered 
together. This is interesting as coordinately regulated genes are only rarely physically linked – 
especially in mammals. This feature, when conserved at a large evolutionary scale, is usually 
considered to be a mark of a positive selection pressure during evolution, itself resulting from 
the existence of local factors critical for the correct regulation of the expression of all genes in 
the cluster. Other famous examples of clusters include the Hox gene cluster, the Major 
Histocompatibility Complex and the Alpha and Beta Haemoglobin clusters. 
Importantly, although the final protein products of the canonical histone genes within a given 
class are almost exactly identical, each has a distinct promoter sequence and gives rise to an 
exclusive mRNA, with specific 5’- and 3’ UTRs and some slight changes in the nucleotide 
composition within the coding sequence.  In yeast the genes encoding histone proteins are 
associated as dimers: H2A and H2B, and H3 and H4, respectively are present in the genome 
on opposite DNA strands as pairs that are transcribed divergently from a common promoter 
(Hereford et al, 1979). In Drosophila single copies of the five genes coding for each of the 
five histones are associated within a 5 kb unit on the long arm of chromosome 2 which is 
repeated about a hundred times. Here again within each repeat the couples H2A-H2B and H3-
H4 are divergently transcribed from opposite strands with only very short distances between 
their transcription start sites (Pardue et al, 1977). The histone H1 is encoded by a single gene 
in Drosophila. 
In mammals more than 75 canonical histone genes have been identified, but although they are 
clustered they are not organized in a repeating structure, nor do they share common 
promoters. Human histone genes are located in three clusters on chromosomes 1 and 6 
(Marzluff et al, 2002). The main cluster, HIST1, is located on chromosome 6 (6p21-p22) and 
contains 55 (80%) histone genes. The two other, smaller clusters, HIST2 and HIST3, are 
located chromosome 1 (at1q21 and at1q42) and contain 6 and 3 histone genes, respectively 
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(Marzluff et al, 2002). Each of the 14 H4 genes encodes the same protein whereas there are 3 
H3 variants encoded by the 12 H3 histone genes and up to 12 variants for both H2A and H2B. 
So far there are only two canonical histone genes known which do not fall into any cluster and 
are expressed during the S phase of the cell cycle. One is the gene coding for the H2AX 
histone variant whose phosphorylation in response to DNA damage is thought to induce a 
modified chromatin state favouring the assembly of repair factors at the lesion and the repair 
reaction itself. The other encodes an H4 variant with an as yet unknown function.  
In addition to the replication-dependent histones genes providing the matrix for non 
polyadenylated histone mRNAs, some histone genes code for polyadenylated mRNAs. Those 
are non cell cycle dependent and encode so-called “replacement histone variants”. Those 
include CENP-A, MacroH2A, H2AZ, H2A-Bbd, H3.3, H1
0
, H1oo. Until now no 
polyadenylated forms of histones H2B or H4 have been detected in mammals. 
 
4.4.2.2. Cajal bodies 
 
In higher eukaryotes histone genes are known to accumulate in or close to specific subnuclear 
bodies containing proteins required for processing and transcription processes. In mammals 
their known under the name Cajal Bodies (CBs) characterized by the presence of coilin 
(Barcaroli et al, 2006b). Typically around 10 of these structures are distinguishable in 
mammalian cells. CBs are sites of spliceosomal snRNP assembly (Carmo-Fonseca et al., 
1992). CBs contain among other factors the U7 snRNP required for the endonucleic cleavage  
(Shopland et al, 2001) and NPAT required for transcription (Ma et al., 2000). CBs also 
contain the Flice-associated huge protein (FLASH) which seems to be required for histone 
mRNA processing (Barcaroli et al, 2006a).  
In Drosophila the histone genes associate with the Histone Locus Bodies (HLBs) which 
contain the U7 snRNP as well as components of the cleavage factor and are distinct 
structures from CBs. Mammalian HLBs may be defined as structures containing U7 snRNP 
and NPAT that are adjacent to histone genes (Ghule et al, 2008). In Xenopus oocytes they are 
known as “spheres” contain all the U7snRNPs in the oocyte and a small amount of SLBP. 
Spheres were found to be located next to the histone gene clusters in Xenopus oocytes 
(Marzluff, 2005). 
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4.4.3. Transcription 
4.4.3.1. Histone biogenesis and metabolism. 
Histone genes are unique and so is the regulation of their expression. Most of the histone 
genes are cell-cycle regulated. These replication dependent histone genes code for the so-
called canonical histones, whose expression must be tightly coupled with the S phase to allow 
correct packaging of newly replicated DNA. To carry out this highly challenging task 
properly the histone genes and their mRNAs evolved very specific features and unique 
mechanisms to make the whole gene expression process as efficient as possible. 
Proliferating eukaryotic cells double their DNA content during the S phase, and 
histone proteins are concomitantly incorporated into newly synthesized DNA. The beginning 
of S phase is associated with a 3-5 fold increase of histone genes transcription by RNA 
polymerase II (Marzluff & Duronio, 2002); a 30-50 fold global increase of histone mRNA 
levels and a 10 fold increase of the efficiency of histone mRNA processing.  
The replication dependent histone mRNAs are the only known mRNAs where the 
3’UTR poly(A) tail (50-300 nt in length) is replaced by a conserved Stem-Loop (SL). This 
structure is followed by an AC-rich element where the adenosines at the second and third 
position present the highest conservation and are essential for function. This 16nt long 
secondary structure is found five nucleotides upstream of the 3’ end of the histone mRNA. It 
consists of a 6 bases stem and a 4 bases invariant loop. Moreover the 5 nucleotides lying 
directly before and after the SL are highly conserved as well. This 25-26-nucleotide sequence 
present a binding site for the Stem Loop Binding Protein (SLBP) (Dominski & Marzluff, 
1999). The SL conformation is stabilized by base stacking interactions and backbone 
hydrogen bonds. 
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Figure 18. The 3’UTR of mammalian histone pre- mRNAs.  
 
 
This specific 3′ end is generated by an endo-nucleolytic cleavage during mRNA maturation. It 
replaces classical pre-mRNA processing consisting of splicing (necessary for intron-
containing genes) and polyadenylation. Instead the formation of the SL results in the 
requirement of a distinct set of factors required for metabolism and regulation of these histone 
mRNAs. Crucial is the fact that the processing and mRNA translation take place during the S 
phase what means that histone mRNAs are subject to a rapid decay at the conclusion of S 
phase or if DNA replication is halted. 
 
4.4.3.2 Transcription regulation. 
 
 
The mammalian canonical histone genes are transcribed by RNA polymerase II. The 
observation that histone genes are clustered together originally suggested a common 
transcription mechanism or common promoters, but astonishingly no unified transcription 
model has been identified. Regulation patterns seem lineage specific and mainly regulated by 
gain or loss of transcription factors on their respective binding sites. Interestingly, while the 
strong correlation between the expression patterns of all canonical histone genes would have 
suggested the existence of conserved promoter sequences, this does not seem to be the case. 
Indeed, canonical histone gene promoters only share weak sequence conservation. However, 
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some conserved sequence elements, located outside of the promoter region, have been 
identified, and they have been shown to affect the regulation of canonical histone gene 
transcription (Table 7).  
 
4.4.3.2.1. The cis-regulatory elements and their trans-acting factors. 
 
Years of studies of histone gene transcription led to the identification of two types of 
conserved sequences acting in cis. Historically the first one was called Subtype Specific 
Consensus Sequences (SSCS) while the second is known as “Coding Region Activating 
Sequence” (CRAS). They bind a distinct set of proteins responsible for the enhancement of 
inhibition of histone gene transcription. 
 
4.4.3.2.1.1. CRAS 
One of the conserved regions which have been identified a decade ago, was the so-called 
“Coding Region Activating Sequence” (CRAS). This element, which is about 110 nucleotides 
long, is common to the four families of canonical core histone genes (H2A, H2B, H3 and H4) 
and is located within the coding region (Bowman et al, 1996; Hurt et al, 1991). More recently 
in rat cells analysis of a H1 linker histone variant gene led to the identification of an 
incomplete CRAS (Horvath et al, 2003). CRAS contain two 7 bp long conserved DNA 
elements: histone alpha α (CATGGCG) and histone ω omega (CGAGATC). The histone α 
element has been found to bind a ubiquitously expressed transcription factor, the Ying-Yang 1 
(YY1) protein (Bowman et al, 1996; Eliassen et al, 1998; Hurt et al, 1989). When bound to 
the CRAS, YY1 enhances the transcription of histone genes during the S phase of the cell 
cycle. 
 
4.4.3.2.1.2. SSCS 
Prior to the discovery of CRAS elements it had been shown that mammalian histone gene 
promoters are also regulated by distinct cis-acting sequences termed Subtype Specific 
Consensus Sequences (SSCS) (La Bella & Heintz, 1991; La Bella et al, 1988). Different 
transcriptional regulators are known to associate with the SSCSs depending on the histone 
subtype.  For example the HINF-P factor has been demonstrated to associate with the SSCS 
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specific for H4. Another transcription factor the Octamer-Binding Protein-1 (OCT-1) together 
with its co-activator OCA-S (OCT-1 co-activator in S phase, a protein complex) is specific for 
the H2B gene promoter. The transcription factor E2F binds the H2A.1 promoter and activates 
its transcription (Oswald et al, 1996). The H1 proximal SSCS associates with the transcription 
factor TF2 in a cell-cycle regulated manner (La Bella & Heintz, 1991). This factor recruits a 
global regulator of histone transcription, the Nuclear Protein Ataxia-Telangiectasia (NPAT) 
(Zhao et al, 2000). Interestingly, immunofluorescence experiments have shown that NPAT 
localises within/or close to Cajal Bodies (CB), nuclear foci that are themselves found in close 
proximity with histone gene clusters (see below). NPAT is phosphorylated at the G1/S phase 
border by the Cyclin-Dependent Kinase 2 E-CDK2 in CBs. Only the phosphorylated form 
endures throughout S phase resulting in an canonical histone gene expression increase. Thus 
NPAT establishes a link between the cell-cycle regulation machinery and the replication-
dependent histone gene transcription (Zhao, 2004) 
 
4.4.3.2.1.3. HIRA  
HIRA (Histone Regulatory Homolog A) was discovered as a transcriptional repressor active 
during the whole cell cycle, except the S phase (Gunjan et al, 2005). Its activity stales the 
cells in S phase by blocking the DNA synthesis. Alike NPATs, HIRAs activity is kinase-
related. In contrast to NPAT phosphorylation by cyclin E-CDK2 at the G1/S phase transition 
(Zhao et al, 2000), phosphorylation of HIRA occurs during S phase by the cyclin A-CDK2 
and E-CDK2) suggesting that this repression factor is inactive in its phosphorylated state. 
Intriguingly HIRA acts both as a transcriptional repressor and as a histone chaperone 
(incorporating the H3.3 histone variant in the nucleosome) (Gunjan et al, 2005). This double 
function remains unexplained.  
It remains obscure how all this factors collaborate in order to ensure a coordinate histone gene 
transcription.  As the cells progress through the cell cycle and enter S phase, cyclin E/cdk2 
dependent phosphorylation of NPAT allows its association with histone promoter sequences. 
NPAT and YY1 then cooperate to promote histone gene transcription, while HIRA becomes 
inactive due to phosphorylation. However, it is thought that stimulation of histone gene 
transcription only makes a minor contribution to the massive augmentation of histone mRNA 
levels and histone protein synthesis expression around the G1/S transition (Baumbach et al, 
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1987; Harris et al, 1991; Sive et al, 1984), indicating that at least one more layer of regulation 
is involved – in all probability at the levels of mRNA stability and/or transcription. 
 
  
Histone Common cis-
acting sequences 
Specific trans 
acting factors 
Global trans-
activator 
Global 
trans- 
repressor 
H2A  
CRAS 
SSCS 
E2F  
NPAT 
YY1 
 
 
HIRA H2B Oct-1, OCA-S 
H3 Unknown 
H4 HINF-P 
H1 TF2 
  
Table 7.  Histone gene transcription regulating sequences and factors found in mammalian cells.  
 
 
3.4.4. Histone pre-mRNA processing. 
 
The transcription results typically in a long 3’extension which requires pre-mRNA 
maturation. Typically a human gene contains 8 exons. In average internal exons are 145 
nucleotides long and introns average more than 10 times this size (Lander et al, 2001). The 
nascent mRNA has to undergoes splicing, 5’capping and 3’polyadenylation. Concomitant 
with increased transcription is an elevated level of histone pre-mRNA processing which 
stabilizes the mRNAs and results in a 35-fold increase of histone mRNA levels. This increase 
is accomplished via upregulation of SLBP levels (Whitfield et al, 2000). Thus, throughout S 
phase histone genes are highly transcribed, their pre-mRNAs efficiently processed and 
packaged into mature messenger ribonucleoproteins (mRNPs) with SLBP, at which point they 
are ready for export to the cytoplasm and translation. 
Although in metazoans replication-dependent histone pre-mRNA processing is quite limited 
compared to canonical pre-mRNAs it remained unexplored for a long time. It is only recently 
that we started getting more understanding about the complexity of the endonuclolytic 
cleavage reaction important for histone pre-mRNA maturation.  
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Since core histone gene transcripts lack introns and are the only known eukaryotic RNAs 
lacking the poly(A) tail, the synthesis of a mature histone mRNA requires only one RNA-
processing reaction. To form a proper 3´end an endonucleolytic cleavage is carried out. 
Analogously to the poly(A)-pre-mRNAs, the nascent histone mRNA presents two typical 
structures on its 3’ end. One is the conserved 26-nucleotide sequence that contains a 16-
nucleotide Stem-Loop (SL) (Fig. 19), the other a purine-rich region, the Histone Downstream 
Element (HDE). The cleavage takes place between these two sequences.  
 
 
Figure. 19 The histone mRNA processing. Several factors are recruited via SLBP and the HDE downstream of SLBP to 
perform a cleavage reaction several nucleotides downstream of the SL. 
 
4.4.4.1  SLBP 
 
The histone mRNA processing is ensured by the Stem Loop Binding Protein (SLBP) bound 
to the stem-loop. This factor is also involved in other steps of histone mRNA metabolism, and 
has his part in the recruitment of the U7 snRNP complex by the HDE (Sullivan et al, 2009b). 
SLBP is a 32 kDa protein with a unique 73 AA RNA Binding Domain (RBD). In somatic 
cells, SLBP is detectable only during S phase of the cell cycle (Whitfield et al, 2000). SLBP 
acts by stabilizing the U7 snRNP on the histone pre-mRNA.  It has been demonstrated both in 
vitro and in vivo that the presence of SLBP, though not absolutely necessary, is critical for 
histone mRNA processing which in the absence of SLBP is only half that efficient. Pandey et 
al. reported that mutations in the SL preventing SLBP binding resulted in the inhibition of 
histone mRNA expression in vivo (Pandey et al, 1994).  
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 4.4.4.2. The mRNA processing complex    
 
The U7 snRNA is measuring only 57-70nt depending on species. Its 5’end contains a 
conserved CUCUU sequence complementary to the AAGAG sequence in the core of HDE 
which is followed by the Sm binding side. The Sm complex is a homolog of the spliceosomal 
snRNPs. Its Sm heteroheptameric ring is composed of Sm Lsm10 and Lsm11 which replace 
the spliceosomal SmD1 and SmD2 (Pillai et al, 2003). SmB and SmD3, interact with the 
region lying in-between the cleavage site and HDE. SmG, E and F complete the structure of 
the ring.  
Another stabilizing factor is a Zinc-finger protein, ZFP100 that interacts with both SLBP 
bound to the SL (Dominski et al, 2002) and the Lsm11 (Azzouz et al, 2005; Wagner & 
Marzluff, 2006). This factor is required for entry into the S phase and is limiting for histone 
pre-RNA processing in vivo (Wagner & Marzluff, 2006).  
Cleavage is catalyzed by CPSF73 (Dominski et al, 2005a) Symplekin and CPSF100. CPSF73 
has been identified as the endonuclease for both polyadenylated (Mandel et al, 2006) and 
histone mRNAs (Dominski et al, 2005b). Symplekin has been originally described as a tight 
junction protein in mammalian cells (Keon et al, 1996). Last but not least, CPSF-100 is like 
CPSF73 a member of the metallo-6-lactamase family of zinc-dependent endonucleases and 
required for cleavage, though it lacks residues critical for catalysis (Kolev et al, 2008).  
The cleavage efficiency requires the interaction between Lsm11 and a recently characterized 
protein FLASH (Yang et al, 2009) that might act as a recruitment factor for CPSF73, CPSF-
100 and symplekin (Yang et al, 2011).  
Once the processing is completed a Downstream Cleavage Product (DCP) is released and 
quickly degraded in order to recycle the U7 snRNP. 
 
4.4.5. Nuclear export 
The more a cell’s nucleus is active the more its envelope will present Nuclear Pore 
Complexes (NPCs). In mammals their number can vary between 3000 and 4000 per nucleus. 
During DNA synthesis the cell needs to deal with the complex task of importing about 10
6
 
histone molecules every 3 minutes from the cytosol. This means that 100 histone molecules 
must pass through each NPC every minute.  
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Simultaneously to transcription mRNA associates with members of the hnRNP family. They 
are believed to modulate many aspects
 
of the nuclear fate of pre-mRNAs, including their 
appropriate
 
processing and folding, and remain associated with nuclear mRNAs
 
after splicing 
is completed. During mRNA nuclear
 
export, some of the hnRNPs, such as hnRNP C, are 
selectively removed
 
at the NPC while others, such as hnRNPs A1 and K, accompany the
 
mature mRNA into the cell cytoplasm and are only then released
 
and returned to the nucleus. 
Different macromolecules and complexes are subject to a distinct export mechanism. Many 
are exported by the importin β-like receptors (for review, see (Fried & Kutay, 2003)).Those 
receptors require Ran, a small GTPase. Some RNAs like tRNA and snRNA are shipped by 
Ran-dependent mechanism. On the contrary most of the canonical PolyA mRNAs require a 
conserved export receptor Nxf1/ TAP (Mex67 in yeast) (Gruter et al, 1998; Segref et al, 
1997).  
4.4.5.1. General mRNA export mechanisms. 
 
Most mRNAs are derived from genes containing introns, which are specifically removed 
during the splicing process prior to nuclear
 
export and translation. Additionally, an m
7
G cap 
and a polyadenylation signal are added at the 5' and 3’ ends, respectively, but neither is 
necessary or sufficient by itself for mRNA export, although both can enhance it (Cullen, 
2003).  
The different pathways for RNA export from the nucleus are listed below: 
 TAP-mediated export 
 The transcription/export or TREX complex that associates with pre-mRNAs during 
transcription elongation (Lei et al, 2001; Strasser et al, 2002; Zenklusen et al, 2002). 
 Aly/REF splicing-dependent mechanism as part of a complex of proteins, the exon 
junction complex (EJC) (Kataoka et al, 2001; Kataoka et al, 2000; Le Hir et al, 2001a; 
Le Hir et al, 2000a).  
 Aly/REF splicing-independent mechanism (Masuyama et al, 2004). Unstructured 
RNA itself can support export factor recruitment and hence serves as an mRNA export 
identity element (Ohno et al, 2002).  
 
None of these mechanisms are mutually exclusive, and it is not clear which mechanism for 
mRNA export adapter recruitment predominates in the cell. 
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4.4.5.2. Histone mRNA export.  
 
Only 8% of human genes are known to be intronless. This suggests a strong evolutionary 
pressure driving the maintenance of at least one intron per gene. Some data reveal the 
importance of new intron insertions in several cellular genes (Fedorova & Fedorov, 2003). 
Most of the intronless genes are expressed transitionally and in extreme conditions like stress-
response. RNAs encoded by those genes are not exported from the nucleus by the same 
mechanism as intron-containing genes. Thus it is likely that cells have evolved an alternative 
export mechanism for non-canonical RNAs. 
 
Some of the non-canonical mRNAs share specific structures/features that have been shown to 
be required for their specific maturation and export pattern. However several reports show 
that intronless genes recruit the same export factors used by the classical RNAs. Among the 
“alternative RNAs” the ones whose export has been most extensively described are those 
coding for (i) histones, (ii) IFN-α1, (iii) Jun and (iv) HSPA1. In the case of histone mRNAs 
the bio-molecular procedures that take place following processing in the nucleus and prior to 
translation are still ill-understood. The nuclear export is thought to be rapid, taking around 5 
min. (Schochetman & Perry, 1972). Evidence coming from mammalian tissue culture cells 
suggests that the histone mRNA 3’ end is necessary for the accumulation of histone mRNAs 
in the cytoplasm and that U7 snRNP-mediated mature 3’end formation facilitates export 
(Eckner et al, 1991). In addition, replication-dependent histone mRNAs have been shown to 
contain specific transport elements in the protein coding region capable of redistributing a 
heterologous mRNA to the cytoplasm (Huang & Carmichael, 1997). These transport elements 
recruit specific adaptors to the mRNAs. There is other evidence for the ability of SR ASF/SF2 
proteins to associate with H2A mRNA in human cells (Lai & Tarn, 2004). A 22nt sequence 
lying in the middle of the H2A mRNA was observed to be the binding site for SR (Huang & 
Steitz, 2001). 
The splicing factors 9G8 and SRp20 can be cross-linked to histone mRNA transport elements 
(Huang & Steitz, 2001) and  9G8 interacts with the mRNA export receptor TAP (Huang et al, 
2003). These observations, and work performed by others (Braun et al, 1999; Huang et al, 
2003), suggest that TAP mediates the export of replication-dependent histone mRNAs from 
the nucleus. Studies from both Drosophila and Xenopus cells (Erkmann et al, 2005; Huang & 
Steitz, 2001) confirmed that nuclear export of histone mRNA is TAP-dependent. Depletion by 
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RNA interference of the export factor TAP leads to nuclear export arrest (Erkmann et al, 
2005). The authors claim as well that the histone mRNA export is SLBP independent since 
mutants of the SL 3’ sequence unable to bind SLBP, failed to affect the nuclear export. It was 
suggested by this group that it is rather the length of the region upstream of the SL, and not 
the sequence of the region itself, which is important for efficient export. However more recent 
studies have shown that deletion of the SL as well as SLBP knockdown result in nuclear RNA 
retention. (Ghule et al, 2008; Sullivan et al, 2009a). Thus, besides its role in the 3’ end 
formation, SLBP is also important for histone mRNA export towards the cytoplasm.  
 
 
4.4.6. Translation 
In 1956 Francis Crick laid out in the “Ideas on Protein Synthesis” the Doctrine of the Triad: 
“Once information has got into a protein it can’t get out again. Information here means the 
sequence of the amino acid residues, or other sequences related to it” (CRICK, 1958). He re-
stated his idea in 1970 in Nature as follows: “The central dogma of molecular biology deals 
with the detailed residue-by-residue transfer of sequential information. It states that 
information cannot be transferred back from protein to either protein or nucleic acid” (Crick, 
1970; CRICK, 1958). 
In other words, the process of producing proteins is irreversible: a protein cannot be used to 
create DNA information. This unique chance to obtain the right polypeptide in the living cell 
occurs immediately after processing and export of the mRNA to the cytoplasm, when the 
molecule is ready to be translated into proteins. In eukaryotes translation is an extremely 
complex process which can be divided in three main stages: initiation, elongation and 
termination. Although the speed of elongation and termination are also important for the rate 
of translation (Cannarozzi et al; Pisarev et al, 2007; Pisarev et al; Tuller et al), the initiation of 
translation is the most controlled step (Jackson et al; Sonenberg & Hinnebusch, 2009). 
4.4.6.1. Translation initiation 
 
During peptide synthesis an mRNA is scanned and translated by ribosomes in a 5’ to 3’ 
direction until it reaches a stop codon. The basic structure ensuring translation in a cell is the 
ribosome. This Ribo-nuclear Particle contains an almost equal amount of ribosomal RNA 
(rRNA) and proteins. Ribosomes are divided into two subunits. The smaller subunit (40S) 
binds to the mRNA, while the larger subunit (60S) binds to the tRNA and the amino acids. 
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Together they form a mature and translationally active ribosome (80S). When a ribosome 
finishes reading the mRNA, these two subunits split apart and are recycled. 
Translation initiation begins with the recruitment of the small 40S ribosomal subunit onto the 
mRNA and ends when the elongation-competent 80S ribosome is assembled and the initiator 
codon is base-paired with the initiator tRNA in the ribosome P-site. It takes up to 13 
eukaryotic Initiation Factors (eIFs) (Fabian et al, 2010; LeFebvre et al, 2006) to ensure proper 
binding of the 40S ribosomal subunit to the RNA and its assembly with the 60S subunit into a 
functional 80S ribosome placed at the correct initiation codon. Therefore, translation initiation 
rates play key roles in many fundamental biological processes such as cell growth, 
differentiation or responses to biological and environmental stress conditions. In eukaryotes 
two different initiation models are to be listed. Firstly the “classical” cap-dependent model, 
secondly the cap-independent one (IRES-driven). In this manuscript I would focus on a novel 
translational model that might be a fusion of these two, providing an extremely efficient 
translational mechanism. This last one evolved in histone mRNAs.     
 
4.4.6.1.1. Cap-dependent translation initiation  
Classical, nuclear-encoded,  poly(A) mRNA translation involves the 5’-terminal m7GpppN 
cap (where N is any nucleotide) (Shatkin, 1976) that enhances initiation by a cap-dependent 
ribosomal scanning mechanism (Kozak, 1978; Kozak, 1989). Cap enhances translation trough 
binding with the eIF4F complex. The cap-dependent translation initiation is comprised of the 
following steps:  
(i) 43S Pre-Initiation Complex (PIC) formation, 
(ii) PIC loading onto the 5’ end of mRNA,  
(iii) mRNA circularization  
(iv) ribosomal scanning of the 5’-UTR, 
(v) initiation codon recognition,  
(vi) ribosomal subunits joining and  
(vii) ribosomal subunits and initiation factors recycling and re-initiation.  
4.4.6.1.1.1. Formation of a 43S pre-initiation complex 
Former to 43S complex formation the 40S subunit is activated by IFs and the initiator tRNA. 
Then tRNAi
Met
 and eIF2-GTP building a ternary complex (TC), bind to the recycled 40S 
small ribosomal subunit, to form the 43S complex stabilized by eIF3, eIF1, eIF1A and 
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probably eIF5. (Benne & Hershey, 1978; Chaudhuri et al, 1999; Chaudhuri et al, 1997; 
Majumdar et al, 2003; Passmore et al, 2007; Peterson et al, 1979; Thomas et al, 1980; 
Trachsel et al, 1977) These factors play further important roles in the succeeding steps of 
translation initiation namely in 43S pre-initiation complex loading onto the mRNA and start 
of codon recognition.  
4.4.6.1.1.2. PIC loading onto the 5’ end of mRNA and mRNA circularization 
 
Despite the interesting ability of the 43S pre-initiation complex to bind mRNA alone and 
promote translation in a 5’ end-dependent manner, the 5’-UTR of eukaryotic mRNAs usually 
contains secondary structures which need to be unwound and prepared for the attachment of 
the 43S pre-initiation complex. This action requires other translation initiation factors as: (i) 
eIF4F holoenzyme binding the 5’ terminal cap-structure and unwinding local structures 
assisted by (ii) eIF4B or (iii) eIF4H creating a fixation platform for the 43S pre-initiation 
complex (Pestova & Kolupaeva, 2002). The eIF4F is a complex comprising the cap-binding 
protein eIF4E, the DEAD-box RNA helicase eIF4A and eIF4G. In its turn eIF4G functions as 
a scaffold binding eIF4E, eIF4A, eIF3 and the Poly(A)-Binding Protein (PABP).  
Through its physical interaction with PABP, eIF4G allows the 5’-3’ cross-talk of the mRNA 
(Imataka et al, 1998; Tarun & Sachs, 1996b; Wells et al, 1998), and performs mRNA 
circularization. In this manner the cap and the poly(A) tail cooperatively lead to an 
enhancement of translation (Preiss & Hentze, 1998; Tarun & Sachs, 1995; Tarun & Sachs, 
1996b).It is still not clear whether the mRNA circularization enhances translation directly or 
only increases the affinity of certain initiation factors  for the translated mRNA (Kahvejian et 
al, 2005). PABP’s binding is regulated by the PABP - Interacting Proteins (PAIPs), PAIP1 
and PAIP2.  PAIP1 contains two binding domains for PABP that lie on either side of a region 
similar to the central portion of eIF4G (MIF4G domain (Roy et al, 2002)). PAIP1 stimulates 
translation by reinforcing the PABP-Poly(A) interaction whereas PAIP2 (A and B) strongly 
inhibits translation. PAIP2 shares homolog regions with PAIP1 (Khaleghpour et al, 2001; Roy 
et al, 2002). It has been shown that the inhibition of translation (in vitro and in vivo) mediated 
by PAIP2 is due to the decrease of PABP’s affinity to the poly(A) tail and to eIF4G thus 
preventing  the mRNA from the circularization, which is dependent on the 5′ and 3′ ends cross 
talk mediated via PABP-eIF4G and PABP-PAIP1-eIF4A (Gingras et al, 1999; Sachs & 
Varani, 2000; Tarun & Sachs, 1996a). Thus both PAIP1 and PAIP2 compete for PABP 
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binding. Further investigations have led to a more complex model PAIP1-PABP-eIF4G and 
PAIP1-eIF3-eIF4G form two ternary complexes. Taken together, these data demonstrate that 
the eIF3-PAIP1 and PAIP1-eIF4G interactions can promote translation initiation where eIF3-
PAIP1 stabilize the interaction between PABP and eIF4G, making the RNA-looping possible 
(Martineau et al, 2008). 
4.4.6.1.1.3. Ribosomal scanning of the 5’-UTR  
 
Right after mRNA circularization follows the stalling of PIC on the mRNA and the formation 
of a 48S pre-initiation complex made up by 43S PIC, eIF3 and eIF4G (Imataka & Sonenberg, 
1997; Korneeva et al, 2000; Lamphear et al, 1995; Ohlmann et al, 1996; Rau et al, 1996; Safer 
et al, 1978). Then the 48S-PIC scans in a 5’ to 3’ direction from the cap structure until it 
reaches an initiation codon. Commonly the initiation starts at the first AUG codon but 
initiation can occur at other codons such as: CUG, GUG, UUG, AUA or ACG (Kozak, 1995; 
Kozak, 1997; Wegrzyn et al, 2008). Scanning of long and structured 5’-UTR needs ATP-
assisted unwinding. The initiation factors: eIF4A, eIF4G and eIF4B, eIF4A are also needed 
for proper scanning but the exact mechanism was not discovered until now. Some recent 
studies highlight the involvement of other RNA helicases such as DHX29 and DDX3/Ded1p 
in the scanning process (Jackson et al, 2010; Parsyan et al, 2009; Pisareva et al, 2008). 
 
 
4.4.6.1.1.3. Ribosomal scanning of the 5’-UTR  
 
The recognition of the initiation codon depends as well on its sequence as on the sequences 
upstream of it. The optimal sequence context seems to be the following:  
GCC(A/G)CCAUGG for AUG initiation codon (Chen et al, 2009; Chen et al, 2008; Kozak, 
1995; Kozak, 1997). Once the ribosome encounters the right initiation codon the ribosome 
40S small subunit becomes anchored on the RNA to be joined by the 60S subunit thereby 
forming an elongation-functional 80S ribosome. The ribosome association as well as the 
simultaneous dissociation of the eIF41, eIF41A, eIF3 and residual eIF2 are eIF5B-mediated. 
 
4.4.6.1.1.5. Recycling 
After the ribosome encounters a STOP codon, the synthesized polypeptide is released by a 
process that depends on eukaryotic release factors eRFs1 and eRF3 (Alkalaeva et al, 2006). 
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At the very end ribosomes are evicted from the RNA and the 40S ribosomal subunits are 
recycled for new rounds of translation by the action of eIF3j, eIF1A, eIF1 and ABCE1. These 
factors dissociate post-termination complexes by displacing elongation factors, 60S subunits, 
deacetylated tRNA and the mRNA allowing the formation of new pre-initiation complexes. 
 
4.4.6.1.2. Cap-independent translation initiation 
Studies of picornavirus translation have permitted to define a new mechanism which is 
mediated by cis acting RNA elements located in the 5’-UTR of the viral mRNA. These RNA 
structures present in the 5’-UTR allow internal binding of the 40S ribosomal subunit with the 
associated initiation factors and are defined as Internal Ribosome Entry Sites (IRES) (Balvay 
et al, 2009; Stoneley & Willis, 2004).  
4.4.6.1.2.1. IRES 
IRES are RNA sequences found in the 5’-UTR of the mRNA. Their function is to recruit 
ribosomes for translation initiation in a cap-independent manner. IRES elements were first 
discovered in viral RNA genomes more than 20 years ago and have been also found in many 
cellular mRNAs. Since then a huge diversity in size, sequence and structure has been 
reported. In total 56 viral and 73 cellular (the first being the immunoglobulin heavy chain 
binding protein) (Macejak & Sarnow, 1991) IRES elements have been characterized and so 
far no evidence for any conserved sequence was found, making a polyphyletic origin 
plausible (Balvay et al, 2007; Balvay et al, 2009). Despite their differences, all IRES elements 
can be defined as an RNA domain that has the ability to recruit ribosomes in a cap-
independent manner. Although it is known that IRES elements require diverse cellular 
accessory proteins (collectively denominated IRES Trans-Acting Factors (ITAFs)) for proper 
function, the mechanism of cellular IRES function remains unclear. IRES-mediated 
translation occurs during many cellular stress conditions that are known to inhibit cap-
dependent translation, including hypoxia, irradiation, apoptosis, angiogenesis, amino-acid 
starvation, continuous heat shock and mitosis. As a result, internal initiation allows the 
translation process to circumvent the cap-dependent control mechanisms, especially the steps 
involving.(Balvay et al, 2007; Balvay et al, 2009) 
The advantage of IRES ribosome positioning for cellular RNA is obvious during shutdown of 
cap-dependent translation. The mRNAs involved for example in cell-cycle control, growth 
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and apoptosis, rely alternatively on internal ribosome entry sequences (IRES). If for any 
reason the cap-dependent translation is inhibited these RNAs remain bound to the polysomes 
and maintain active expression. Interestingly, it has been reported that mRNAs synthesizing 
proteins requested during mitosis undergo an IRES-driven translation initiation (Cornelis et 
al, 2000). Pyronnet et al. 2000; Sachs 2000). The precise mechanism of translation via cellular 
IRES and its regulation as well as how cellular mRNAs can switch from cap- to IRES-
dependent translation initiation remains unclear. 
4.4.6.1.3. Histone mRNA specific translation – towards a new translation model.  
 
The expression of these cell-cycle regulated, multi-copy replication-dependent genes is a 
unique occurrence in living organisms. As mentioned before histone mRNAs are the only 
mRNAs ending with a conserved RNA hairpin element (Stem Loop) and lacking a poly(A) 
tail. Therefore it comes as no surprise that their translation has been shown to differ a great 
way from the classical model in both Vertebrates and Drosophila.  
During the S phase a great number of histones is demanded. The histone genes are principally 
expressed in the mid-S phase (van der Meijden et al, 2002), meaning that during around one 
hour 60 million copies of each core histone have to be synthesized. Such a challenging task 
suggests the existence of an extremely efficient and fine controlled translation mechanism. As 
previously reported translation during the S phase is cap-dependent (Pyronnet et al, 2001; 
Pyronnet & Sonenberg, 2001). 
The discovery of the importance of both the RNA hairpin element and its binding protein 
SLBP (or HBP) for histone mRNA translation revolutionized the view on cap-dependent 
translation. 
4.4.6.1.3.2. Implication of the 5’UTR in the initiation of translation. 
 
Until recently most of the studies of histone mRNA translation focused on the unique 3’UTR 
of the replication dependent histone genes, not taking into account the characteristics of the 5’ 
terminus since it was known to present a usual cap-structure. As described before mRNA 
scanning is one of the crucial steps of translation initiation. Until recentely this step was 
believed to be an attribute of canonical cap-dependent translation initiation. Histone mRNAs 
are known to present particularly short 5’UTRs, especially those coding for histone H4. This 
feature means that these mRNAs are not fit substrates for the classical mechanism of 
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ribosomal scanning. Recent work by Martin and co-workers demonstrated that within H4 
mRNA two structural elements are essential for translation initiation. The first recruits eIF4E 
while the second conceals the cap. Binding of eIF4E to the first element allows ribosomal 
tethering trough eIF4E even though the cap is not accessible. Thus the 43S PICis is directly 
loaded close to the start codon. The second structure is located 19 nt downstream of the 
initiation codon and forms a characteristic “three-way helix junction”. Both of these elements 
are thus believed to assist in the correct placement of the ribosome on a relevant start codon.   
The authors propose a combined-translation model where the cap being hidden in the three-
way helix is not available so the ribosome has to be tethered directly on an AUG instead of 
scanning for the start codon. One notable advantage of such an initiation mechanism is the 
absence of a pioneer translation round to promote the CBC-eIF4E exchange (Ishigaki et al, 
2001). This confers a greater efficiency of translation initiation in that the H4 mRNA-eIF4E 
complex is immediately “ready to go” for translation (Martin et al, 2011). 
Interestingly, this model of histone translation model combines in an elegant way features of 
both the canonical and IRES-dependent models of translation initiation. 
 
4.4.6.1.3.1 Implication of the 3’UTR in the initiation of translation. 
 
Interestingly some similarities between Poly(A)-mediated and SL-driven translational model 
can be found.  The analysis of SLBP interacting partners revealed the need of eIF4E, eIF4G, 
and eIF3 for correct translation initiation. Moreover SLBP co-purified with cap- and poly(A)-
associated initiation complexes. It was shown that the interaction of SLBP with eIF4F was 
mediated by eIF4G and eIF3 indicating that SLBP is functionally similar to PABP. Thus the 
enhancement of translation initiation involves contacts of SLBP with the cap-interacting 
initiation factors (Gorgoni et al, 2005; Ling et al, 2002b). 
 
4.4.6.1.3.1.1. SLIP-1 /MIF4GD 
 
From the previously described models it can be concluded that SLBP occupies a central role 
in the histone translational model. Recent studies highlight a novel protein required for 
histone mRNA translation. It has been identified in a two hybrid screen performed with SLBP 
as bait which was accordingly named SLBP Interacting Protein 1 (SLIP-1) (Cakmakci et al, 
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2008b). This small 25 kD protein corresponds almost entirely to a middle domain of 
eukaryotic initiation factor 4G (MIF4G) and is therefore called as well MIF4G Domain 
Containing Protein (MIF4GD). The study by the Cakmakci group provides evidence for 
SLIP-1 strongly stimulating histone mRNA translation trough the interaction with SLBP. 
Surprisingly SLIP-1 interacts as well with eIF4G. This binding takes places on another site 
than the one known for PABP. Importantly this interaction seems to be direct unlike that 
between SLBP and eIF4G. This indicates that SLIP-1 acts as a bridge between SLBP and 
eIF4G  and in this way helps the cross-talk between the 3’ and 5’ termini of histone mRNA. 
 
In canonical RNAs the looping of the RNA is guaranteed by the formation of ternary 
complexes composed of PAIP1-PABP-eIF4G and PAIP1-eIF3-eIF4G (Martineau et al, 2008). 
Importantly Martineau et al. have shown that the interaction of PAIP1 with eIF3 takes place 
through the g subunit of eIF3. However they also revealed EIF3E (INT6) in a far-western 
experiment. Although the 3’ end of the histone gene lacks a poly(A) tail, the general mRNP 
organization allowing efficient translation initiation might be very similar and thus the 
following histone translation model emerges: 5’RNA cap- eIF4E-eIF4G-eIF3(?)-SLIPl-
SLBP-3' RNA SL structure. The couple SLBP-SLIP1 might though act in a similar way as 
PABP-PAIP1 by allowing looping of the RNA along with contacts with eIF4G and eIF3. This 
model is still incomplete. One can imagine other initiation factors, for example some of the 
IF3 subunits stabilizing the protein-protein interactions necessary for RNA circularization 
and/or initiating the translation machinery. 
 
4.4.7. RNA degradation.  
 
The initial step in degradation of most polyadenylated mRNAs in eukaryotes is shortening of 
the poly(A) tail by a deadenylase complex (Parker & Song, 2004). Deadenylated mRNAs can 
then either return to a translationally active state on polysomes, likely by the enzymatic action 
of cytoplasmic poly(A) polymerases (Coller & Parker, 2005), or can alternately be degraded 
from either terminus by a distinct set of nucleases.  
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Table 8. An overview of factors involved in canonical histone gene expression.  
 
4.4.7.1. Histone mRNA degradation. 
 
 
Following the end of S phase and the associated stop to DNA synthesis activities, the level of 
histone mRNAs promptly decreases. The half-life of histone mRNAs drops from 45-60 
minutes to 10 minutes, leading to near complete elimination of histone mRNAs in G2 
(Marzluff & Duronio, 2002). These results suggest that histone expression relies mainly on 
the posttranscriptional regulation of histone mRNAs (Fig.20)  
 
Process Canonical histone mRNA 
specific 
Shared with polyadenylated 
mRNAs 
Transcription NPAT, HIRA(repression 
factor) 
TBP, HINFd, YY-1, OCT1, 
OCA-S 
Processing SLBP, U7 snRNP (snRNA, 
Lsm-10, Lsm-11), ZFP100, 
FLASH 
Symplekin, CPSF-100, CPSF73, 
FIP1, Sm 
Export SLBP TAP, Rev 
Translation SLBP,SLIP,INT6 EIF3, EIF4GI, EIF4GII 
mRNA Decay SLBP, TUTase Lsm1, exosome, UPF1, DCP, 
XRN1 
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Figure 20. Cell cycle regulation of canonical histone mRNA along with SLBP. The presence of SLBP determines the 
maximal levels of replication-dependent histone mRNA that can accumulate in the cytoplasm. As cells reach the end of S 
phase, replication-dependent histone mRNA is rapidly degraded, along with SLBP 
 
The degradation process is also dependent upon translation since cycloheximide treatment 
stabilizes histone mRNAs (Kaygun & Marzluff, 2005b). Histone mRNAs are degraded as a 
result of stopping DNA synthesis, and SLBP is degraded as a result of phosphorylation by 
cyclinA/Cdkl (Kaygun & Marzluff, 2005b). The expression of SLBP coincides with that of 
histones and is therefore cell-cycle dependent. SLBP accompanies the nascent histone mRNA 
from the processing in the nucleus until the end of the S phase where it undergoes itself rapid 
degradation. Regarding this process it has been shown that SLBP interacts with UPF1 (one of 
the main/core RNA decay factors) at the 3’end of histone mRNA immediately after inhibition 
of DNA replication and UPF1 plays therefore a direct role in histone mRNA decay (Kaygun 
& Marzluff, 2005b; Kaygun & Marzluff, 2005c). For proper decay a modification of the 3’ 
end by oligourydilation (oligo(U)) (Mullen & Marzluff, 2008)  is required. 
The 8-12 nt oligo(U) tail added by the Terminal Urydylyl Transferase (TUTase) at the 3’ end 
provides a specific binding platform for Lsm 1-7, which together with SLBP, binds the 
histone mRNA. (Mullen & Marzluff, 2008) Lsm 1-7 complex probably recruits the enzymes 
executing the histone mRNA, as it does for the classical polyadenylated mRNAs (Parker & 
Song, 2004). Degradation involves the 5’-3’ XRN1 exonuclease and the exosome in the 3’-5’ 
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direction (Fig. 21).  Together it results in a bidirectional decay mechanism for histone 
mRNAs in mammals. 
 
 
 
 
Figure 21 Model of histone mRNA and SLBP degradation. A proposed model of histone mRNA degradation showing the 
transition of histone mRNA from active translation as a circular mRNA, followed by the recruitment of Upf1 to the 3′ end 
(Kaygun & Marzluff, 2005b) when DNA replication is inhibited, followed by oligouridylation and degradation. SLBP itself 
undergoes phosphorylation in the presence of kinases (CDK1, cyclin A). 
 
 
4.4.8. Histone protein degradation. 
Any excess of the histones in the cell is extremely hazardous because of their highly basic 
character resulting in non-specific binding to nucleic acids and non-nucleosomal aggregate 
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forming. Therefore it is absolutely critical for the cell to maintain a perfect balance between 
histone production and degradation.  
 
4.4.8.1. Rad 53 
 
Not many data are available concerning the degradation of histone proteins. Some reports 
coming from Yeast studies suggested a novel role of Rad53 in histone excess degradation. 
More specifically Rad53 is reported to prevent the accumulation of nonnucleosomal histone 
proteins in the cell. Cells which lack Rad53 are unable to deal with the consequences of 
histone overexpression. Although the precise mechanism remains unclear it is interesting to 
notice that Rad53 is able to directly co-purify with canonical histones.  Since Rad53 is known 
to be the homolog of Chk2 present in higher eukaryotes it might be interesting to investigate 
the impact of Chk2 on histone degradation, in human cells (Gunjan & Verreault, 2003). 
 
4.4.8.1. GrnA 
 
In human cells the Cytotoxic T lymphocytes (CTL) protease Granzyme A (GrnA) induces 
caspase-independent cell death. Dong Zhang et al studies bring evidence for GrnA being 
involved in histone degradation. In vitro and GrnA completely degrades histone H1 and 
cleaves core histones into ∼16-kDa fragments (Zhang et al, 2001). 
Even if these two examples are interesting especially because they propose new functions for 
already known factors more research has to be done in order to elucidate a possible common 
model of histone protein degradation. 
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 “A perfection of means, and confusion of aims, seems to be our main problem.”  
Albert Einstein 
 
Main objectives.  
The main objective of this work was to gain further insights into the molecular mechanisms 
controlling gene expression on the posttranscriptional and translational level. In particular this 
work concentrated on the role of the protein INT6 in different RNA-related processes: 
1. Study the role of the protein INT6 in the context of canonical histone mRNA 
translation. As seen previously, this process obeys to different mechanisms than that 
of classical mRNAs in line with the specific requirements associated with histone 
synthesis. INT6 had been previously shown to be part of the eIF3 translation complex 
but non-essential for global translation. Its interaction with SLIP-1 – one of the key 
players of the histone mRNA-specific translation mechanism – suggested that INT6 
may participate in the still ill-understood process of histone mRNA translation. 
 
2. Study the molecular interactions between INT6 and other components participating in 
the mRNA quality control quality Nonsense Mediated mRNA Decay (NMD), and try 
to understand the role played by INT6 in this process. Our laboratory has previously 
established an interaction between INT6 and two core NMD factors UPF1 and UPF2 
and shown that INT6 itself participates in this surveillance mechanism, but its precise 
role in it is still incompletely understood. 
 
3. Understand the role of the association of the HTLV-1 protein Tax with INT6 and in 
particular – since HTLV-1 mRNAs exhibits several key features common with the usual 
NMD targets – to understand whether HTLV-1 may not hamper the NMD pathway through 
this interaction. 
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Article I 
The HTLV-1 Tax protein inhibits nonsense-mediated mRNA decay by interacting with 
INT6/EIF3E and UPF1. 
 
Vincent Mocquet1,6, Julia Neusiedler1,6, Francesca Rende5, Jean–Michel Terme1*, 
Madeleine Duc Dodon2, Jürgen Wittman3, Christelle Morris1, Franck Mortreux1, Eric 
Wattel1,  Vincenzo Ciminale5 and Pierre Jalinot1. 
6 These authors equally contributed to this work. 
 
Context of study and summary 
 
Our previous results having shown an interaction between the protein INT6 and the HTLV-1 
transcriptional activator Tax, we set out to characterize the effects and role of this association. 
INT6 is a dispensable subunit of the translation factor EIF3, and previous work by our 
laboratory had shown that it participates in the Nonsense-Mediated mRNA Decay (NMD), a 
translation- and splicing-dependent mRNA quality control mechanism that recognizes 
premature termination codon (PTC)-containing mRNAs. Importantly, although NMD acts at 
the mRNA level, it is actually thought to be important for tumour suppression, as many 
potential mutations would result in the generation of abnormal mRNAs featuring a PTC that 
could be efficiently recognized and degraded by the NMD. We had observed that INT6 
interacts with the core NMD factors UPF1 and UPF2 and that INT6 removal results in the 
stabilization of PTC-containing mRNAs, thus firmly establishing INT6 as a new NMD factor.  
We thus decided to test whether Tax may affect NMD through its interaction with INT6. 
Because of the tendency of viruses to encode their genetic information in a minimal space, 
their RNAs are often atypical and many present features such as extensive alternative 
splicing, bicistronism, long 3’UTRs and leaky ribosome scanning, which could result in their 
targeting by the NMD.   
We started by deciphering the interaction network between Tax, INT6 and the UPFs by 
immunoprecipitation experiments. Co-immunoprecipitation experiments demonstrated that 
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Tax interacts with UPF1, UPF2, UPF3b, and INT6, which are known to participate in NMD. 
More precisely the interaction with UPFs is mediated via UPF1 and especially its 
phosphorylated form. Our data suggest that the interaction of Tax and INT6 prevents the latter 
from interacting with the UPF1-UPF2 complex. Additional effects of Tax expression were an 
increase in size and abundance of UPF1-containing P-bodies. This could be explained by the 
stabilization of the interaction between the phospho-UPF1 and SMG5 observed in the 
presence of Tax. We further investigated the impact of Tax upon the mRNA. RNA-binding 
protein immunoprecipitation (RIP) experiments showed that Tax was able to associate with 
NMD-prone mRNA. The NMD tests demonstrated that Tax is able to increase the stability of 
transcripts normally subjected to NMD. This inhibition of NMD by Tax is INT6 dependent. 
We found these effects with different physiological RNAs as well as HTLV-1 transcripts. We 
concluded that HTLV-1 RNAs are sensitive to NMD and that Tax actively interferes with this 
mechanism.  
Collectively, these data support the notion that Tax which trans-activates the expression of 
viral and cellular genes by binding to various enhancer-binding proteins, needed for 
transcription, has an impact on the NMD and interferes at the post-transcriptional level of 
gene regulation. 
Our findings show that HTLV-1 is capable of manipulating the cell to make it more tolerant 
to external or internal messenger RNAs which are normally subjected to degradation. This is 
likely to favour the transformation of infected cells by allowing PTC-containing mRNAs 
derived from mutated genes to persist. This work will contribute to a better understanding of 
both the basics of NMD and some effects of HTLV-1 infection on cell transformation.  
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Article II 
INT6 interacts with MIF4GD/SLIP1 and is necessary for efficient histone mRNA 
translation.  
 
Julia Neusiedler#, Vincent Mocquet#, Christelle Morris and Pierre Jalinot* 
# Both authors contributed equally to this work 
 
Context of study and summary 
 
This study focuses on the investigation of the translation of histone mRNAs which are derived 
from cell-cycle regulated, multicopy replication-dependent histone genes. Histone mRNAs 
are unique mRNAs ending with a conserved RNA hairpin element (steam-loop structure) and 
lacking a 3’ poly(A) tail. In Metazoans, their translation and stability has been shown to be 
dependent on a 3’ stem-loop that binds to SLBP and its interacting partner SLIP1. However 
the details of this process are only partially understood. In the following document we show 
that the INT6 protein binds to SLIP1 and SLBP. Moreover we demonstrate that INT6 itself is 
required for efficient translation of histone mRNA.  
 The INT6 protein (which is one of the 13 subunits of eIF3) has been shown previously to 
contact other translation factors including EIF1, 1A, and eIF4G. In our laboratory INT6 was 
shown to play an important role in cell cycle regulation. INT6 silencing by RNA interference 
in HeLa cells causes an increased number of cells in the G2/M phases of the cell cycle, along 
with mitotic defects and chromosome segregation defects. In accordance with our previous 
findings and given the interaction between INT6 and SLIP1 and SLBP we decided to 
investigate their functional with the aim of understanding the conserved mechanism of histone 
mRNA translation. 
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Indeed the data presented in this manuscript demonstrate that a knockdown of INT6 results in 
a 2 fold decrease in histone mRNA translation during S phase while the mRNA levels are not 
or only slightly affected. The down regulation of histone mRNA translation rate was validated 
by a luciferase reporter system and by measuring the level of newly synthesized endogenous 
histones. Similarly both luciferase-derived RNAs and endogenous RNA levels have been 
tested and no significant changes have been observed supporting the conclusion that the 
action of INT6 on the histone biogenesis takes place at the translational level. 
This work brings new facts important for the understanding of the similarities and the 
differences between the classical translation mechanism and the histone mRNA specific one. 
We conclude from these data that INT6 by establishing interactions with SLIP1 and SLBP 
plays an important role in translation of canonical histone mRNAs and thereby opens new 
perspectives to understand its role in oncogenesis. 
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Part III Discussion 
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„One never notices what has been done; one can only see what remains to be done.” 
Maria Skłodowska - Curie 
 
General discussion and perspectives. 
 
  
1.1 INT6/EIF3E is required for translation of specific mRNAs, notably for histone 
mRNA. 
Previous studies of INT6 function seem to strongly support its role in histone mRNA 
translation. Although human EIF3E/INT6 was originally described as a subunit of a 
translation initiation factor (Asano et al, 1997a), its role in this process remains controversial.  
However a specific subset of mRNAs has been observed to be regulated by INT6 (Grzmil et 
al, 2010). Further evidence for INT6 being implicated in the translation of specific mRNAs is 
provided by very recent studies showing that the expression of one of the truncated forms of 
INT6 provokes a shift from cap-dependent to IRES-mediated translation initiation. The 
mutant used to study this phenomenon is called 3e5 and is a result of MMTV integration at 
intron 5 (one of the natural sites of integration of the MMTV).  
This integration has been formerly shown to be sufficient to induce malignant transformation 
of mammalian cells (Mack et al, 2007; Mayeur & Hershey, 2002; Rencus-Lazar et al, 2008). 
It has been suggested that the expression of 3e5 was the cause of tumorigenesis, rather than 
the loss of an eif3e allele (Chiluiza et al, 2011). The authors propose a model in which the 
expression of the C-terminal truncated mutant would compete with the wild-type form for the 
binding to eIF4G. This would result in the inhibition of mRNA binding to the 43S PIC. The 
translation of mRNAs which is strictly cap-dependent would the most affected since its 
efficiency depends on the eIF4G-associated unwinding machinery of the secondary structures 
in the 5’UTR. These findings support the idea that INT6 is important for the cap-dependent 
translation of a subgroup of mRNAs (i.e. GAPDH, actine). This is interesting from the point 
of view that histone mRNAs are also translated in a cap-dependant manner; this has been at 
least demonstrated in the case of H4 coding mRNA (Martin et al, 2011). 
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Another interesting point to consider is the fact that most – but not all – mRNAs are translated 
at the strongest rate in the G1 phase of the cell cycle and at the lowest rate during mitosis 
(Pyronnet & Sonenberg, 2001). These changes correlate with the activity of several canonical 
translation initiation factors, modulated during the cell cycle to regulate translation. However, 
some mRNAs, like histone mRNAs, have very different patterns of cell cycle-dependent 
regulation. INT6 is set apart from the other eIF3 subunits by the fact that it exists both in the 
nucleus and the cytoplasm and can shuttle between both compartments. Watkins and Norbury 
have reported that in primary human fibroblasts, but not their transformed counterparts, a 
subpopulation of cells has reduced nuclear EIF3E/INT6. After synchronization in S phase, the 
percentage of cells where nuclear INT6 is reduced reaches 40% (Watkins & Norbury, 2004a). 
These findings suggest that during S phase INT6 could be required in greater quantities in the 
cytoplasm, and it is tempting to suggest that its function could be in part to allow the 
assembly of the complete eIF3 on histone mRNAs as well as the establishment of various 
interactions with other general translation initiation factors. INT6 associated to SLIP1, SLBP 
and through them to the histone mRNAs in the nucleus, might be replaced by a complete eIF3 
complex once it reaches the cytoplasm. To test this notion it would be interesting to analyse in 
details the dynamics of the recruitment of the various eIF3 subunits to this particular type of 
mRNA. Another, non-exclusive hypothesis is that INT6 could be required for histone mRNA 
export. Some studies indicate that histone mRNAs are exported via a TAP dependent 
mechanism (Huang & Steitz, 2001).  Studies of the implication of SLBP itself in the export 
process remain controversial. Indeed, although SLBP has been shown to be required for this 
process (Ghule et al, 2008; Sullivan et al, 2009a), it has not yet been demonstrated to present 
an NES, while INT6 does have one. Thus, it would be of great interest to test the importance 
of the existence of a nuclear pool of INT6 and of correct INT6 shuttling for accurate histone 
mRNA export. Finally, since INT6 is also important for translation of many different classes 
of mRNA, such as mRNAs involved in apoptosis. For instance it has been shown that the 
translation of the mRNA coding for the antiapoptotic protein BCL-XL is stimulated by INT6 
(Grzmil et al, 2010). It would also be interesting to test whether modifications of the 
subcellular distribution of INT6 correlate with the conditions in which these classes of 
mRNAs are produced and translated. Alternatively, S phase relocation of INT6 may be a way 
to regulate the function of other complexes it associates with, such as the COP9 signalosome. 
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1.2. The diversity of INT6 functions and its link with histone mRNA translation. 
The discovery that histones are more than just a protection for the double-helix and a tool to 
organize it properly in the cell nucleus provoked an avalanche of studies. Histones are 
involved in the control of DNA replication, transcription, repair and recombination, which 
makes of them one of the chief proteins of DNA metabolism. Any alteration of histone 
synthesis has thus extreme consequences for the phenotype of the cell and can ultimately 
result in cell death or transformation. 
A previous study performed in our laboratory revealed the presence of INT6 at chromosomes 
in the mid-zone of the mitotic spindle (Morris & Jalinot, 2005).  The same study reported that 
the loss of INT6 causes significant mitosis defects such as spindle aberrations and ultimately 
results in faulty chromosome segregation. This effect was demonstrated to be due to the 
inhibition of cyclin B-Cdk1 kinase activity. The data presented in this report revealed that this 
inhibition correlates with a prolonged phosphorylated state of Cdk1 which in turn resulted 
from the absence of INT6. 
Intriguingly the INT6/EIF3E protein has been also identified as an interacting partner of 
MCM7, and the interaction is thought to be direct (Buchsbaum et al, 2007; Grzmil et al, 2010) 
This DNA replication licensing factor is part of the Mini-Chromosome Maintenance complex 
(MCM2-7) which is essential for the initiation and progression of eukaryotic genome 
replication and is thought to be the replicative helicase. INT6 has been shown to stabilize 
polyubiquitinylated, chromatin-bound MCM7. Interestingly, both MCM7 and INT6 silencing 
resulted in a significant slowing down of the replication machinery (Buchsbaum et al, 2007).  
The question arises if it is possible that INT6 acts as a sensor of DNA replication progression 
and by doing so allows the synchronisation of this process with histone expression. INT6 
might favour histone synthesis in the cytoplasm, while its nuclear pool would be rather an 
enhancer of replication by stabilizing the MCM7. This way INT6 could accelerate both of 
these phenomena. The fine tuning of these two processes could be regulated via the control of 
the speed of nuclear import-export of INT6 and through it the relative size of the cytoplasmic 
and nuclear pools of the protein, authorizing both replication in the nucleus and translation of 
histone mRNAs in the cytoplasm. Such a control mechanism would aid to establish the 
delicate balance between the amount of histones and the newly doubled DNA. Future studies 
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should help to establish the validity of such a model and to determine precisely if both of 
these activities of INT6 are independent or related. 
 
 
1.3. The activity of INT6 in histone mRNA translation involves interaction with SLIP-1 
and SLBP 
Our group has identified two new interaction partners of INT6: SLIP-1 (MIF4GD) and SLBP. 
These two proteins have been shown previously to be required for histone mRNA translation 
(Cakmakci et al, 2008a; Ling et al, 2002a). We propose that INT6 plays a role in this 
mechanism through these interactions. Previously LeFebvre et al have described an in vitro 
interaction between the 1015-1118 region of eIF4G1 and the eIF3 complex. This interaction 
would involve a contact with INT6 as observed by performing partial proteolysis and mass 
spectrometry analyses (LeFebvre et al, 2006). SLIP-1 in turn has been observed to interact 
with eIF4G through its N-terminal region (amino acids 27 to 170, (Cakmakci et al, 2008a)). 
Thus it is possible that INT6 interacts simultaneously with both MIF4GD and eIF4G1, 
thereby playing a pivotal role in histone mRNA translation. The question arises as to whether 
INT6 forms separate complexes with SLIP-1, SLBP and eIF4G1 or if all these proteins are 
present in a single complex (Fig. 22). Sub-complexes could be formed during the initiation of 
translation. This idea would be supported by the fact that SLIP-1 is a dimer protein and thus 
could easily bind to more than just one partner. Our preliminary data suggest the existence of 
a subcomplex made up of INT6, SLIP-1 and SLBP. Although we observed that SLIP-1 is not 
necessary for the interaction between INT6 and SLBP, it seems that this interaction is more 
stable when all three proteins are present. 
Additionally INT6 binding near the carboxyl end of eIF4G and SLIP-1 at its amino end might 
result in possible conformation changes of the scaffold protein eIF4G. This conformational 
change could be the event that brings together the two termini of the mRNA. 
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Figure 22 Model of Histone mRNA translation. Here we propose a hypothetic model of the association of known factors 
required for histone mRNA translation. In this model INT6 is loaded early on the RNA via the interaction with SLBP and 
accompanies it from the nucleus to the cytoplasm. A translationally active complex is formed in the cytoplasm once SLIP-1 
joins the other initiation factors.   
 
1.4. Histone mRNA and protein degradation. 
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Although the present work concentrated on the involvement of INT6 in histone mRNA 
translation, it is possible that INT6 also intervenes at (a) further step(s) of histone mRNAs 
metabolism. Indeed, once genome replication is completed histone expression stops and their 
mRNAs are degraded in a process which involves SLBP and UPF1, the latter being a core 
NMD factor (Kaygun & Marzluff, 2005a). Our previous studies demonstrated that INT6 
interacts with UPF2 and UPF1 and is important for the NMD process (Morris et al, 2007). 
Given our results which show that INT6 interacts strongly with SLBP, it would be interesting 
to investigate the effect of INT6 on histone mRNA in late S-phase and G2/M. To better 
understand this point it will be important to determine the exact role played by UPF1 and 
RNA degradation factors in the process. Our preliminary data from G2/M-synchronized and 
INT6-depleted cells might aid to understand this process. To our surprise we observed in 
these experiments an increased histone level in INT6-deficient cells. However, this effect 
cannot be (uniquely) explained by changes in mRNA levels since those stayed stable or were 
only slightly increased. Hence it is possible that after playing a positive role on histone 
synthesis in S phase, INT6 also participates in histone degradation in G2. Since it is known 
that INT6 interacts with the 26S proteasome subunits (Hoareau Alves et al, 2002) and that in 
Schizosaccharomyces Pombe it positively regulates the proteasome 26S via an association 
with the regulatory subunit Rpn5 (Yen et al, 2003) it would be interesting to test if INT6 
might participate in histone or SLBP degradation via one of these complexes. Little is known 
about the degradation of excess free histones or their direct degradation via the proteasome. 
From studies performed in budding yeast we know that histone protein levels are regulated by 
phosphorylation and the ubiquitin-proteasome pathway. The CHK-1/2 homolog Rad53 is 
implicated in this phosphorylation process. In fission yeast Ams2 activates histone 
transcription at the G1/S transition.  As the cells exit the S phase, Ams2 is phosphorylated by 
DDK, leading to its degradation via the SCF
Pof3
-ubiquitin proteasome pathway. It has been 
also proposed that SLBP is degraded via the ubiquitin-proteasome pathway (Takayama & 
Toda, 2010). Thus it seems that rather than histone degradation, another lead to follow might 
be the decay of SLBP at the S/G2 border. As previously established this protein is actively 
degraded at the end of the S-phase and is indispensible for histone synthesis. However, the 
molecular basis underlying this degradation is not known. Before degradation SLBP has to be 
phosphorylated and ejected from the SL (Zheng et al, 2003). The phosphorylation takes place 
on two threonines 60 and 61 and requires the cyclin A/cdk1 and CK2 (Kaygun & Marzluff, 
2005b). Even if the molecular details of regulatory systems may vary between species, the 
200 
 
underlying principles of histone homeostasis, maintained via ubiquitin-mediated proteolysis 
could be conserved from yeast to human beings. Interestingly we observe a stabilization of 
histone protein levels in absence of INT6 in the G2/M phase. This phenomenon could be also 
due to the stabilization of SLBP on histone mRNAs. INT6 might be implicated in the 
degradation of SLBP via the proteasome since INT6 has been shown to associate with the lid 
of the 26S proteasome. 
 
1.5. Implication of INT6 in multiple degradation pathways.  
INT6 has been reported to control the stability of specific cellular proteins. As described 
above INT6 stabilizes chromatin-bound MCM7, which also happens to be the 
polyubiquitylated fraction of the protein. Different evidence has been brought for HIF-2α 
(Hypoxia Inducible Factor 2) to be stabilized in the absence of INT6. INT6 has also been 
shown to negatively control the stability of the steroid coreceptor 3 (SRC3) during mitosis 
(Suo et al, 2010). The fact that INT6 acts in a different manner on the stability of selective 
proteins might be related to its presence in two different protein degradation complexes, the 
Proteasome and the CSN.  
Interesting data related to the subject of the role of INT6 in protein degradation have been 
obtained from studies of the INT6 fission yeast homolog, Yin6. It has been shown that in yin6 
null cells chromosomes are improperly segregated. This improper segregation has been 
proposed to be due to the inhibition of securin/Cut2 degradation via the proteasome (Yen et 
al, 2003). Another recent report coming from the same group suggests that Yin6 might be 
important for the regulation of the ERAD-degradation pathway (Otero et al, 2010). ERAD 
stands for Endoplasmic Reticulum Associated Protein Degradation and is a pathway which 
targets misfolded proteins of the ER for polyubiquitylation and subsequent degradation by the 
proteasome. According to these data, Yin6 acts together with two interacting partners, Cdc48 
and Moe1, to control the ERAD degradation pathway (Otero et al, 2010). It is interesting to 
note that the properties of these proteins seem to be evolutionarily conserved in humans. 
Human Cdc48 is notably able to rescue the lethality of the yeast cdc48Δ mutant, and Int6 and 
Moe1/eIF3d bind Cdc48 in human cells. This might open new possibilities to explain how 
these proteins are involved in specific protein degradation. It would be very interesting to link 
the potential role of INT6 in proteasome-mediated protein degradation to its function in the 
pioneer translation round. During this pre-scanning of mRNAs short peptides are synthesized 
which have to be degraded. One could imagine a role of INT6 in this degradation. 
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1.6. Tax, histones and INT6: is there any link? 
Since Tax – the transcriptional activator of HTLV-1 – has been demonstrated to interact with 
INT6 (Desbois et al, 1996) and this later protein has been revealed in the current work as 
important for histone mRNA translation we were wondering if Tax may have an impact on 
the histone mRNA translation.  
Our understanding of the multitude of ways in which viruses either commandeer or are 
controlled by cellular pathways is constantly evolving, and far from complete.  
Tax has been shown to interfere with a broad range of cellular mechanisms, such as cellular 
proliferation, DNA repair and cell cycle control. All of these effects of Tax are thought to 
cooperate in the development of ATL. A recent study claimed that the expression of Tax in 
HTLV-1 infected T-cells decreases histone protein levels and that the expression of Tax in 
Jurkat cells diminishes the level of replication-dependent histone transcripts. The group of P.J. 
Leybourn demonstrates that both HTLV-1 infection and Tax expression result in reduction of 
the H1 linker histone protein level and the core H3 histone level in human Tcells 
(Bogenberger & Laybourn, 2008). In line with earlier studies showing that Tax, by blocking 
checkpoint controls, results in unregulated initiation of S phase, impairs histones synthesis 
and provokes octamer disassembly, the impact of Tax on histone biogenesis is not very 
surprising. Tax inhibition of histone gene expression could result in incomplete chromatin 
assembly during DNA replication in S phase, leading to increased incidence of DNA double 
strand breaks and greater chromosome instability. In normal somatic cells, histone gene 
expression is tightly coupled to DNA replication in S phase and is mainly regulated at the 
mRNA level. These results suggest a novel mean by which Tax may induce genomic 
instability. However, preliminary results obtained in our team do not seem to confirm the 
results of the Leyboum group. Indeed, in our experiments Tax expression in JPX9 inducible 
cells instead resulted in a stabilization of histone protein levels, suggesting a stimulation 
translation. 
Importantly, the increased histone protein level observed in presence of Tax did not correlate 
with any changes at the transcript level. The same result was observed for two different 
experiments, one in which reporter mRNA derived from a transfected plasmid were 
monitored, another in which endogenous histone mRNA levels were analysed by RT qPCR. 
The drastic differences between our data and the ones already published may be due to (i) the 
use of different cell types by both groups, (ii) different core histones studied, (iii) the use of a 
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luciferase-reporter system (in our case), (iv) a non-specific effect – such as transcriptional 
squelching - due to non-physiological levels of expression of the transfected protein in one of 
the conflicting experiments. In our study we observed an increase of H2A and H4 in the 
presence of Tax whereas Leybourn’s group concentrated on the linker histone H1 and the core 
histone H3. Furthermore we were able to detect a significant reduction of SLBP levels in 
presence of Tax. This could be due to an enhanced degradation of SLBP, which is induced by 
its phosphorylation by the CDK2 kinase (Koseoglu et al, 2008). CDK2 has been previously 
identified as being stimulated by Tax (Haller et al, 2002). This potential effect makes the 
correct interpretation of the phenotype of Tax expression very complicated and leaves many 
possibilities open. We would like to investigate an overall effect of Tax expression on the 
protein level of endogenous histones. Tax may act on one or several levels during histone 
biogenesis. Proteins like HIRA, NPAT, SLBP or SLIP-1 which function downstream of 
cyclin E-Cdk2 in histone gene regulation, might be affected. 
 
The plausible implication of INT6 in the post-ERAD short peptide degradation and the 
hypothesis of INT6 controlling the stability of SLBP, bring us to the second part of my 
discussion which will be more focused on the implication of INT6 in the NMD pathway 
(Morris et al, 2007) and another role of the interaction between the viral protein Tax and INT6 
(Desbois et al, 1996).  
 
1.7. INT6 as an emerging, central player in the NMD pathway 
The work described in this manuscript strengthens the prior findings of an important role of 
INT6 in the NMD. It has been shown that INT6 removal from the cell clearly results in the 
stabilization of PTC-containing mRNAs (Morris et al, 2007). In the present work we confirm 
also the interaction between INT6 and Tax (Desbois et al, 1996) and the one between INT6 
and UPF1 (Morris et al, 2007).  
 An as yet unresolved issue, that is immediately relevant to the newly discovered role of INT6 
in the NMD, is the precise timing of its association with RNA. Previous work indicates that 
INT6 might be present at early as well as at late steps of the processing of an mRNA targeted 
for degradation (Asano et al, 1998; Hoareau Alves et al, 2002; Morris et al, 2007; Zhou et al, 
2005). From our own unpublished data we know that a fraction of INT6 is associated with 
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chromatin and with the RNA polymerase II holoenzyme (P Jalinot and J-M Egly, unpublished 
data). Although this remains to be firmly established, the possibility exists that INT6 could be 
loaded very early on the nascent mRNA, and its interaction with the CBP80 subunit of the 
Cap Binding Complex is in line with such a notion (Morris et al, 2007). This early loading of 
INT6 is compatible with INT6 being implicated in the pioneer round of translation and thus in 
the NMD.  
1.8. The HTLV-1 Tax protein as a tool to study the role of INT6 in the NMD pathway 
Since their discovery viruses have been shown to have evolved mechanisms not only to evade 
eradication by cellular pathways, but also to manipulate them for enhanced viral replication 
and gene expression. Our understanding of how many of these pathways are normally 
targeted is still incomplete, as new discoveries are made on a frequent basis. Ironically, 
because of their tight association with the complex cellular networks, viruses are powerful 
tools to help deconstruct those same networks, in our case those which govern eukaryotic 
RNA stability. 
INT6 was first identified as a product of a gene which is frequently disrupted by Mouse 
Mammary Tumour Virus (MMTV) integration in MMTV-induced tumour cells; it was 
subsequently discovered independently a second time as an interactor of Tax. This example of 
two independent discoveries of a same protein through its targeting by viruses is only one of a 
plethora illustrating how viruses can help to discover cellular proteins and investigate their 
function.  
Given our findings that INT6 is both involved in NMD and a target of Tax, we addressed the 
question of a putative Tax impact on the NMD. The features of the HTLV-1 genome make it 
a possible target of NMD. Indeed we observed that Tax was able to inhibit the NMD 
suggesting a possible protective mechanism the virus might have developed. This will be 
described further in this chapter. 
 We started deciphering the interaction network between the viral protein, INT6 and the 
UPFs. We were able to demonstrate that Tax binds directly both proteins and by doing so 
disrupts their association. Studies using Tax also led to the observation of a delocalization of 
NMD factors in the cells upon tax expression. This was observed by performing 
immunofluorescence analysis of the subcellular localisation of these proteins. In Tax 
transfected cells immunofluorescence experiments revealed that Tax disrupted the partial 
localization of INT6 within P-bodies. Interestingly we were able to detect Tax itself within the 
P-bodies. Moreover, whereas under normal conditions UPF1 is hardly detectable in P-bodies 
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– although expression of an HA-tagged form of the protein slightly facilitates observations of 
cytoplasmic foci colocalizing with those formed by the P-body marker DCP1-RFP – Tax was 
able to markedly enhance the presence of UPF1 in these P-bodies. Tax expression also 
modified the aspect of these subcellular structures. Indeed the number of P-bodies increased 
and they were also larger than in cells lacking Tax. This effect is likely to result from the 
inhibition of mRNA degradation, as a similar one has been observed in other cases (Durand et 
al, 2007a; Sheth & Parker, 2006). P-bodies have been already revealed as a target of other 
viruses. For example the Hantavirus nucleocapsid peptide (N) protects and sequesters mRNA 
caps in P bodies. These stored caps are then used during the initiation of viral mRNA 
synthesis (Mir et al, 2008). 
These observations are compatible with the hypothesis that Tax, by interacting with INT6, 
UPF1 or both, inhibits processing of NMD-prone mRNAs. We observed an interaction of Tax 
with the phosphorylated form of UPF1 (a form that interacts with degradation factors and 
which is localized in the P-bodies). We found that Tax expression stabilizes phospho-UPF1, 
thus inhibiting the correct recycling of this core NMD factor and probably triggering its 
observed accumulation in the P-bodies. A reasonable hypothesis would be that the reduced 
NMD efficiency observed in presence of Tax results from the decrease in available 
dephosphorylated UPF1 – the form active in NMD – triggered by the viral protein. However, 
analysis of several Tax mutants indicates that the effect of the viral protein on NMD cannot 
be completely attributed to its interaction with UPF1. Indeed, the Tax M47 mutant – which 
binds UPF1 slightly more efficiently than wt Tax but does not associate with INT6 – was 
found not active in NMD inhibition and did not affect the P-bodies. This indicates that the 
association of Tax with INT6 is important for functional inhibition of the NMD. Given the 
numerous interactions of Tax with cellular proteins and the number of pathways this viral 
protein has been demonstrated to have an impact on (reviewed in: (Boxus et al, 2008), it is 
highly possible that its interaction with UPF1 could target other activities of UPF1 than 
NMD. Indeed, UPF1 has been shown to participate in other decay mechanisms such as SMD 
or histone mRNA decay (functions of NMD factors outside the core NMD pathway have been 
reviewed by Nicholson et al: (Nicholson et al, 2010). Our findings open new possibilities to 
complete the complex picture of effects connected with the expression of Tax during viral 
infection. So far our observations support an effect of Tax on at least two different steps of the 
NMD. . 
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1.9. NMD: an antiviral mechanism? 
Our data also demonstrate that HTLV-1 is targeted by the NMD pathway and that Tax 
significantly decreases NMD activity. The viral mRNAs expression downstream of activated 
transcription is also regulated at the posttranscriptional level. We have shown that Tax 
increases ~2.6 times the half-life of the hbz mRNA. One could presume that NMD constitutes 
a barrier for viral infection since many viruses present polycistronic transcripts which, during 
translation of the first ORF, would have an unusually long 3’UTRs which may elicit NMD. 
Moreover viruses often use alternative splicing to maximize coding potential, possibly 
creating spliced variants with EJC components remaining downstream of the stop codon used 
by the 5’ORF. NMD has been shown to be inhibited by infection with the polio virus, which 
cleaves and inactivates the eukaryotic initiation factors eIF4GI and eIF4GII and poly(A)-
binding protein (PABP) (Carter et al, 1995). 
 The regulation of the splicing pattern is another way to prevent the NMD. The HIV-1 
genome is spliced in a way that genes are always spliced out sequentially in a 5’to 3’order. 
Most of cellular mRNAs lack introns in the 3’UTR which are a signal eliciting the NMD. In 
the case of HIV-1 the splicing of a 3′ intron is tightly inhibited unless the 5′ intron is removed. 
This avoids generating transcripts where splicing of 3’ genes leads to deposition of EJCs 
downstream of the termination codons of the 5’genes (Bohne et al, 2005). 
 
Some viruses also specifically avoid NMD by encoding protective elements within their long 
3’UTRs. An example is another retrovirus, the Rous Sarcoma Virus, which contains an RNA 
stability element (RSE) downstream of the gag gene stop codon. The RSE is thought to 
interact with unknown cellular factors to allow viral mRNAs to avoid destruction by the 
NMD pathway and promote proper translation (Withers & Beemon, 2010). Deletion of this 
sequence causes a dramatic shortening of the half-life of unspliced RSV mRNA in a 
translation- and UPF1-dependent manner, whereas insertion of the RSE protects PTC-
containing NMD substrates from degradation.   
Collectively, these findings illustrate how different viruses can disturb the posttranscriptional 
quality control or the translational machinery itself. Although the NMD has been associated 
before with the host-pathogen interactions of retroviruses and other viruses, including some 
oncoviruses (Amor et al, 2010; LeBlanc & Beemon, 2004), we demonstrate for the first time 
that a viral protein actively interferes with this pathway and that HTLV-1 is part of these 
206 
 
NMD-targeted-viruses. It would be tempting to test if the NMD core machinery is a target of 
other viruses, especially other retroviruses. 
The observation that many viruses inactivate the NMD pathway raises the question as to 
whether NMD is part of the innate intracellular antiviral response. Although the hypothesis is 
tempting, another more conservative explanation can be proposed. Viral genomes are 
characterised by a high density of information in a relatively small space and by atypical 
structures and mechanisms, in all likeliness to maximise the number of viral copies that can 
assemble from a single infected cell. These peculiarities mean that viral mRNAs often differ 
sensibly from normal cellular mRNAs and may thus be recognized as abnormal by cellular 
mRNA quality control mechanisms. Thus, NMD and other mRNA quality control 
mechanisms, or any more general cellular processes targeted by viruses, may not necessarily 
have evolved as a barrier to viral infection, but instead be normal cellular mechanism that 
evolved to perform functions in non-infected cells which viruses only target because the only 
evolutive pathway they have found to package genetic information at a higher density than the 
host cells was to develop atypical structures that are recognized as abnormal by host cells. 
 
1.10. Impact of Tax-mediated NMD inhibition on the stress response. 
Viral infection is one of the factors conducting to a stress response in the cell. NMD has also 
been shown to degrade transcripts that participate in the adaptive response of cells to their 
microenvironment (Gardner, 2008; Mendell et al, 2004). NMD activation/inhibition is also an 
important regulatory step in the Unfolded Protein Response (UPR) to the ER stress response 
(Gardner, 2010). A feature of ER stress is the upregulation of  xbp-1. Interestingly this type of 
stress is commonly induced after viral infection, (Ni et al, 2009). Since NMD inhibition leads 
to the expression of truncated and potentially misfolded proteins, Tax could be a key player in 
the activation of these pathways, thus explaining the up-regulation of xbp-1 mRNA.  
Another interesting example comes from hypoxic cells where the eIF2α initiation factor is 
phosphorylated. The phosphorylation of eIF2α is known to promote translational and 
transcriptional up-regulation of genes important for the cellular stress response. It has been 
observed that the mRNAs of several of these stress-induced genes are NMD targets. eIF2α 
phosphorylation also represses NMD, thus stabilizing these mRNAs. This supports the idea 
that the inhibition of NMD increases the cellular stress response. Thus paradoxically the 
phospho-eIF2α-mediated inhibition of the NMD pathway is an important adaptive behaviour 
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of the cell in response to stress during tumorigenesis (Fels & Koumenis, 2006; Gardner, 
2008).   
In response to environmental stress and viral infection, mammalian cells postpone the 
translation of most cellular mRNAs and usually form foci termed stress granules (SGs). The 
temporally silenced mRNAs are gathered in the SGs and can undergo normal translation once 
the stress agent is eliminated, or are alternatively re-routed for degradation in other 
cytoplasmic compartments such as P-bodies. Subsequent to viral infection phosphorylation of 
eIF2α leading to translational repression has often been observed. However we observed that 
eIF2α is not phosphorylated in the presence of Tax (data not shown). This suggests that the 
action of Tax on the NMD pathway provokes an abnormal stress response. This goes along 
with the involvement of Tax in the cellular stress response defect that was recently identified 
due to its impact on the formation of stress granules after stress exposure (Legros et al, 2011). 
However in our experimental approach we did not test the effect of viral infection but only of 
Tax overexpression. These two events are likely to have different effects on the cellular stress 
response. Importantly these findings even strengthen our conclusion that Tax directly targets 
the NMD core machinery and does not provoke NMD inhibition via translational arrest which 
is one of the events following eIF2α phosphorylation. 
 
1.11. Deregulation of NMD by the Tax protein 
The HTLV-1 Tax protein has been described as a potent transactivator of provirus 
expression, but also as an immortalising protein with pleiotropic activities (reviewed in: 
(Matsuoka & Jeang, 2007)). In this report, we show a novel effect of this viral factor on the 
inhibition of the NMD pathway. This was observed both with the β-globin model system and 
with endogenous genes such as GADD45α, ATF4, SLIT2 and BAG1. In line with these 
functional effects, Tax has been observed to co-precipitate with UPF1, UPF2, UPF3b and 
INT6 in cells with an integrated and transcriptionally active provirus. In the case of UPF2, the 
association with Tax was observed to be mediated by UPF1.  
This consequence of the NMD inhibition in HTLV-1 cells would be in line with the described 
mutagenic effects of Tax during the infection. For instance a recent study evaluates that the 
NMD-sensitive telomerase mRNAs were upregulated in Marek's Disease Virus (MDV) T-cell 
lymphoma (Amor et al). In our report, we limited the analysis to the study of mRNA from 
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genes already described to be stabilised after silencing of UPF1, UPF2 and INT6 (Mendell et 
al, 2004; Morris et al, 2007; Wittmann et al, 2006). Future systematic studies of NMD-
sensitive transcripts increased by Tax should help to define how this activity of Tax 
contributes to cell transformation. Regarding this novel Tax function, we also observed that 
Tax associates with NMD-prone mRNAs. This is true for Gl NS39 reporter mRNA as well as 
endogenous mRNAs such as GADD45α, whereas Tax did not bind MAP3K14 whose half-life 
is not increased by Tax. At this step it is not clear whether the association intervenes very 
early after transcription or if it occurs after the pioneer round of translation once UPF1 has 
been phosphorylated. It is possible that a weak interaction occurs early, similar to what 
happens with UPF1 (Hogg & Goff, 2010; Hwang et al, 2010), and that this interaction is then 
stabilized after UPF1 phosphorylation.  
 Among the deregulated genes analysed, ATF4 (also called CREB-2) has often been 
associated with the biology of HTLV-1. The expression of this gene, like many in the 
genome, is regulated by the NMD not due to the presence of PTCs, but to that of three 
uORFs. Tax, by inhibiting the NMD pathway, stabilises ATF4 mRNA (the half-life is 
increased ~3 times) which would be expected to result in higher translation. ATF4 protein up-
regulation by NMD inhibition is a well described pathway (Gardner, 2008). ATF4 has been 
involved in transactivation of the LTR, meaning that the NMD inhibition could result in an 
increased HTLV-1 genome transcription. However the role of ATF4 during HTLV-1 
infection could also be related to its capacity to heterodimerize with AP-1 family factors to 
activate AP-1 responsive genes, which has already been associated with T cells 
transformation (Ameri & Harris, 2008). 
 
Final conclusions  
 
Our studies shed new light on the initiation of the translation of cell cycle-coupled, canonical 
histone mRNAs. In this work we identify INT6 as a new key player necessary for efficient 
histone mRNA translation.  It is likely that the involvement of INT6 in this process is the 
result of its physical interactions with SLIP-1 and SLBP.  
The second part of my project allowed the strengthening of the previous findings concerning 
the implication of INT6 in the NMD mechanism. This study also suggested a potential 
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explanation as to how the interaction between Tax and INT6 may contribute to the oncogenic 
process triggered by Tax.  In conclusion, although NMD has already been associated with the 
host-pathogen biology of retroviruses and other oncoviruses, we report here for the first time 
that a viral protein actively interferes with this pathway and that HTLV-1 is part of the class 
of viruses the replication of which requires NMD inactivation. 
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